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ABSTRACT 
Bisbenzylisoquinoline (BBIQ) alkaloids are a very large and structurally diverse 
family of compounds, which can exist in up to 28 possible types. These compounds have 
been isolated from a variety of different plant sources and are found to exhibit a 
multitude of pharmacological properties including antitumor, antimalarial, and 
antibacterial activities. Variation in the number of oxygen substituents on the aromatic 
rings present, the number of ether linkages, the nature of the ether bridges and the sites on 
the two benzylisoquinoline units where the ether or carbon-carbon bonds originate, have 
made BBIQ's very interesting targets for several synthetic endeavours. 
The research described herein focuses on the asymmetric synthesis of the BBIQ 
(-)-cycleanine, and several other compounds of interest. The mild Cu(OAc)2-promoted 
diaryl ether formation methodology was applied to construct the target molecule. Crystals 
of the key precursor to the diary! ether formation step were obtained and the absolute 
configuration of a new stereogenic center was established based on the X-ray 
crystallography analysis. The use of a chiral auxiliary-assisted diastereoselective 
Bischler-Napieralski cyclization is discussed. 
In addition, a new approach to the synthesis of isoquinolones thalifoline, 
corydaldine and N-methylcorydaldine is investigated utilizing the Bischler-Napieralski 
strategy for the isoquinolines formation. Furthermore, regioselecti ve oxidation of 
tetrahydroquinolines by using Ru02-Na104 is explored. 
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CHAPTER! 
INTRODUCTION 
1.1 Structures and Sources of BBIQ Alkaloids 
Bisbenzyltetrahydroisoquinoline (BBIQ) alkaloids are represented by 
approximately two hundred compounds, which occur primarily in the Families 
Berberidaceae, Menispermaceae, Monimiaceae and Ranunculaceae. 1 It is believed that 
one of the earliest applications of a BBIQ alkaloid is as a component of the arrow poison 
Curare used by some indigenous South American tribes. 1 Natural products chemists and 
pharmacists have been interested in the BBIQ alkaloids because of their diverse 
structures and varied pharmacological effects. Most of the literature on the BBIQ 
alkaloids is focused on their sources, structures and pharmacological activities. 1-4 
1.1.1 Botanical Source 
Ecological factors affect the nature and the quantities of BBIQ alkaloids found in 
plants. Different groups of BBIQ alkaloids are distributed in different genera, and a 
single one may contain one major BBIQ alkaloid and some other minor alkaloids. 
Moreover, the alkaloids vary in their relative proportions in different parts of the plant. 
For example, in the case of Mahonia fortunei Fedde, the trunk is found to contain 
berbamine and oxyacanthine, but its leaves do not contain any BBIQ alkaloids.5 
1.1.2 Structure 
BBIQ alkaloids are composed of two benzyltetrahydroisoquinoline (BI) units 
linked by ether bridges. As well, methylenoxy bridging or direct carbon-carbon bonding 
between the two BI units is also found. According to Guha1 and Shamma,6 BBIQ 
1 
alkaloids are classified into 5 groups and 28 types, based on differences in their structural 
patterns: (1) the number of oxygen substituents on the aromatic rings; (2) the number of 
ether linkages; (3) the nature of ether bridges, viz., diphenyl ether or benzylphenyl ether; 
and ( 4) the sites on the two BI units at which the ether or the carbon-carbon bond 
originate. 1 Most types of BBIQ alkaloid belong to groups A, B and C. Groups D and E 
only contain a few members. 
4 OR 
OR 
II ' 
la: Type I of Group A: one diphenyl ether linkage 
R:;:;CH3 orH 
lb: Type VI of Group B: two diphenyl ether linkages 
R:;:;CH3 orH 
4 
~12 
13 
lc: Type XXII of Group C: one diphenyl ether and 
one benzyl phenyl ether linkage R:;:;CH3 or H 
4 4' 
3' 
#12 OR 
13 II ' 
ld: Type XXIII of Group D: three ether linkages 
R:;:;CH3 orH 
Figure 1. Four structural types of BBIQ alkaloids 
Figure 1 contains four different structures: la according to Guha' s classification, 
is an example of a structural Type I of Group A, and is characterized by one diphenyl 
ether linkage between the two "tail-to-tail" connecting subunits; lb is an example of a 
structural Type VI of Group B, with two diphenyl ether linkages between the two 
tetrahydroisoquinoline units, with a "head-to-head" and "tail-to-tail" connecting pattern; 
2 
lc is an example of a structural Type XXTI of Group C with one diphenyl ether and one 
benzyl phenyl ether linkage between the two subunits; ld is an example of a structural 
Type XXlli of Group D, with two tetrahydroisoquinoline units connected by three 
diphenyl ether linkages. 
1.2. Pharmacological Activities of BBIQ Alkaloids 
BBIQ alkaloids have been widely demonstrated to possess potent biological 
activities, including anti-tumor, anti-inflammatory, antibiotic, anti-hypertensive and anti-
plasmodial activities.4 The pharmacological activity of several BBIQs is outlined in Table 
1, which shows that anti-inflammatory action is common to those compounds and that 
individual alkaloids usually have multiple pharmacological activities. 
BBIQs, therefore, are potentially potent, non-toxic therapeutic agents that inhibit 
inflammation and biological oxidation.4 Over the past thirty years, many researchers have 
tried to reveal the relationship between the structure features of BBIQs and their 
1 lR,l 'S- berbamine R1:::; CH3, Rz :::;CH3, R3:::; H 
4 lS, l 'S-tetrandrine R1 :::;CH3, Rz :::;CH3, R3:::;CH3 
7 lS,l 'S- fangchinoline R1 :::; CH3, Rz :::; H, R3:::; CH3 
2 lR,l 'S- cepharanthine R 1 :::; CH3, Rz :::; CH3, R3 = CH3 
3 lR, l 'S- aromoline R1 = H, R2 = CH3, R3 = H 
5 lS, l 'R - oxyacanthine R1 = CH3, Rz = CH3, R3 = H 
6 lS, l 'S- repandine R1 = CH3, Rz = CH3, R3 = H 
3 
pharmacological activities. 2• 24 It was reported by Wright25 and Galle26 that chirality and 
substitution play roles in aiding in the selective interaction with various substrates. 
Although chirality and substitution patterns are believed to be related to the activities of 
BBIQs, 25• 26 no conclusions have been made about exactly how these structural features 
of BBIQs affect their biological activities. 
Table 1. Selected pharmacological activities of several BBIQ alkaloids 
Alkaloid Structural Pharmacological Activity 
Type 
Berbamine (1) VITI anti plasmodial/ anti -inflammatory, 8- 11 
Cepharanthine (2) VI 
Arornoline (3) VI 
Tetrandrine ( 4) vm 
Oxyacanthine (5) VI 
(-)-Repandine (6) X 
Fangchinoline (7) Vlli 
1.3 Syntheses of BBIQs 
anti proliferative, 12 antioxidant13 
anti-inflammatory, 14 analgesic 15 
anti-inflammatory, 16 antiplasmodial 17 
inhibition ofT -Cell dependant immune responses, 18 
. 1 di 1 19 . . fl 12 20-22 antlp asmo a , anti-m arnmatory · 
anti-inflarnmatory,9- 11 antioxidant, 13 antiproliferative12 
anti plasmodial, 19 anti-inflarnrnatorl· 14 
antiplasmodial, anti-inflarnrnator/3 
In spite of the vast literature on the isolation of BBIQs from different parts of 
plants, their structure determinations and their biological activities, there is relatively 
little on their syntheses. The complexity of these compounds makes their syntheses a 
4 
great challenge. Undertaken in the 1960s and early 1970s, the work of the main early 
researchers on the syntheses of BBIQs, Tomita, 24' 27-29 Inubushi30 and Kametani,31 -33 was 
reviewed by Shamma et al. 2 The syntheses of oxyacanthine, berbamine and related 
compounds were reported by Inubushi and Kametani, while Tomita focused on the 
synthesis of the isochondodendrine type of BBIQ, e.g. cycleanine (8). Unfortunately, 
(-)-Cycleanine (8) 
each group experienced the same problems associated with regioselectivity, 
diastereoselectivity and coupling difficulties. 
In 2002, Wang and Georghiou34 completed the first enantioselective total 
synthesis of (-)-tejedine (9), a seco-bisbenzyltetrahydroisoquinoline, which was isolated 
(-)-Tejedine (9) 
5 
in 1998 as a minor component from Berberis vulgaris.35 This synthesis was accomplished 
with four key steps in which a chiral auxiliary-assisted diastereoselective Bischler-
Napieralski cyclization (BNC) strategy was employed. A mild Cu(OAc)z-mediated diaryl 
ether coupling methodology recently developed by Evans36 and Chan37 was successfully 
applied in the (-)-tejedine synthesis. This also formed the main synthetic strategy 
employed towards the formation of diaryl ethers described in this thesis and will be 
described in greater detail in the following sections. 
1.4 Cycleanine 
Cycleanine (8) (0,0-dimethylisochondodendrine) is a C2-symmetrical compound 
with two benzyltetrahydroisoquinoline units connected by two diary! ether linkages. It 
was first isolated from Cyclea insularis (MAKINO) DIELS and Stephania cepharantha 
HAY AT A in 1937 by Kondo et al. 38 Cycleanine is a "head-to-tail" dimer and is a Type 
XX, Group B, BBIQ. 
1.4.1 Pharmacological Activities of Cycleanine 
Cycleanine can be obtained from the root bark of the plant Synclisia scarbrida 
Miers (Menispermanceae), a slender woody creeper found in Southern Nigeria and other 
coastal regions of West Africa. The root bark is widely used in traditional medicine to 
treat various ailments such as acute psychosis, dysmenorrhea and threatened abortion. 
Men in southern Nigeria have been reported to use the root powder also as an 
aphrodisiac. Cycleanine has also been reported to be an analgesic, muscle relaxant and 
anti-inflammatory. 15 Wambebe et al.39 evaluated the cycleanine activity in the central 
nervous system and uterotonic effects. They revealed that cycleanine significantly 
6 
reduced spontaneous motor activities (SMA) in a dose-related manner and evoked 
concentration-dependent contractions that were resistant to atropine but were blocked by 
salbutamol. 
Although further investigations are needed to identify structure-activity 
relationships for the biological activity of cycleanine, clearly the compound has many 
10 12 13 
( dl)-Cycleanine 
14 
Scheme 1. 
7 
properties which make it of pharmacological interest. 
1.4.2 Previous Synthetic Approaches towards Cycleanine 
Most of the previous synthetic efforts towards cycleanine were made by Tomita, 
et a/. 27-29 They completed the first synthesis of (d/)-cycleanine in 1966.28 The outline of 
their synthesis is displayed in Scheme 1. Condensation between the N-Cbz carboxylic 
acid 10 and the methyl ester 11 gave an amide 12 with the aid of dicyclohexylcarbo-
diimide (DCC) in dichloromethane. Deprotection of the amino group and ester 
hydrolysis, followed by a second condensation reaction using DCC gave the cyclic 
diamide 13. Bischler-Napieralski cyclization (BNC) of the cyclic diamide 13 followed by 
sodium borohydride reduction gave a mixture of tetrahydroisoquinolines, that after N-
methylation, produced a mixture of (dl)-cycleanine and its regioisomers. This approach 
was not synthetically useful because of the very low yield of the ring-closure step 
( <1 0% ), the formation of a mixture of diastereoisomers and the lack of regioselectivity. 
Br 
15 
Attempted Dua l 
Ullmann Coupling 
OH 
16 17 
Scheme 2. 
8 
Tomita's other attempted synthesis of cycleanine, which is shown in Scheme 2, 
via a dual Ullmann coupling reaction was disappointing.29 This approach endeavoured to 
form the dual Ullmann coupling product cyclic diamine 17 from the 8-bromoarmepavine 
15. However, the attempts gave only the linear diamine 16, which could not be further 
coupled. 
Although the synthesis of this alkaloid was unsuccessful, information gained from 
the attempted syntheses by Tomita et al. was valuable. As a result of their efforts, the 
main problems associated with the formation of the macrocyclic ether linkages and the 
determination of the correct regiochemical result from the tetrahydroisoquinoline ring 
closure were partly solved. With the development of modem synthetic techniques, it was 
postulated that those difficulties might be overcome more effectively. In this thesis, a 
Cu(OAc)2-mediated diaryl ether formation methodology is discussed. In order to solve 
the problem of the regioselectivity, an enantiomerically pure subisoquinoline unit as a 
precursor of the diaryl ·ether-macroether ring-closure step was successfully synthesized. 
This accomplishment could be helpful towards reaching the target molecule in the future. 
1.5 Benzyltetrahydroisoquinolones 
1.5.1 Benzyltetrahydroisoquinolones 
Benzyltetrahydroisoquinolones are a group of alkaloids that are present only in 
minor amounts in certain plants. Since these compounds are minor constituents in sources 
that produce alkaloids derived from benzyltetrahydroisoquinoline units, their origin is 
most likely a result of biochemical oxidation of these major products.40 This hypothesis 
was presented in Tomita's report.41 ' 42 The presence of hemandaline (18) and thalifoline 
9 
(19)43 in the same plant possibly results from the oxidation of the dimeric 
benzylisoquinoline-aporphine dimer, thalicarpine (20),41 which is known to occur in the 
same species.42 It should not be surprising, therefore, that thalifoline, first isolated from 
Thalictrum minus L. Var. adiantifolium Hort by R. W. Doskotch et al. in 1969,43 was 
found to be a subunit of (-)-tejedine (9)?4 
H 
OCH3 
( + )-Hemandaline (18) 
( + )-Thalicarpine (20) 
Thalifoline (19) 
N-Methylcorydaldine (21) R=CH3 
Corydaldine (22) R=H 
N-Methylcorydaldine (21),44 isolated in 1971 from Thalictrumfendleri Engelm. 
ex Gray, as a colourless oil, was found to be devoid of cytotoxicity when measured by the 
degree of inhibition of protein synthesis with monolayer KB cell cultures. Corydaldine 
10 
(22), 45 another member of this small, rare group of isoquinolones, is known to have 
medicinal importance.46 No other studies have been reported on the biological activity of 
these isoquinolone compounds. 
Although these isoquinolones are relatively rare compounds and there are only a 
few reports on their biological activity, it is important to study the syntheses of such 
compounds using potentially efficient methodologies, which may be used in the 
syntheses of other BBIQ alkaloids. This thesis will describe approaches towards the 
syntheses of thalifoline (19), N-methylcorydaldine (21), corydaldine (22) and related 
structures using newly developed selective C-1 oxidation methodologies,47 which may be 
applicable to the total syntheses of BBIQs. 
1.5.2 Previous Synthetic Approaches towards Isoquinolones 
Compared to the great interest in the synthesis of isoquinolines, only a few 
syntheses of isoquinolones have been reported. It is known that tetrahydrobenzyl-
isoquinolines can be oxidized to form isoquinolones using potassium permanganate. 
Doskotch et al. 43 completed a synthesis of thalifoline (19) using this methodology in less 
than 10% overall yield using vanillin (23) as the starting material. In 2002, Wang and 
Georghiou achieved the synthesis of this target molecule efficiently by a multistep 
synthesis with 37% overall yield.48 The synthesis is illustrated in Scheme 3. 
11 
Conditions: (a) BnBr/K2C03, acetone, reflux, 98%; (b) CH3N02/NH4Ac, CH3COOH, reflux, 90%; 
(c) LiAlH4, THF, reflux; (d) HCOOC2H5, reflux, 78%, two steps; (e) BH3/THF, BF3/Et20, THF, 
reflux; (f) 1. CICOOC2H5; 2. NaHC03, CH2ClrH20, 0°C, 60%, two steps; (g) Tf20/DMAP, 
CH2Cl2, 0°C, 90%; (h) H2/Pd/C, methanol, 99%. 
Scheme 3. 
This approach also started from vanillin (23). After six straightforward steps, the 
key intermediate carbamate 26 was obtained in 41% overall yield. The penultimate step is 
no doubt the most impressive reaction in the synthesis. Under conditions which employ a 
cotnbination of trifluoromethanesulfonic anhydride (TfzO) and 4-dimethylaminopyridine 
(DMAP) as discovered by Ban well et al.,49' 50 an efficient cyclization of the carbamate 26 
was achieved to afford 0-benzylthalifoline 27, which was easily converted to the target 
molecule 19 by hydrogenolysis. 
Recently, Huang et al.51 reported oxidation of N-methyltetrahydroisoquinolines 
with iodosylbenzene (ISB) in the presence of a catalytic amount of tetrabutylammonium 
iodide in various solvents to afford the corresponding amide isoquinolones in almost 
quantitative yields. Corydaldine (22), N-methylcorydaldine (21) and other iso-quinolones 
were similarly obtained by oxidation of the corresponding isoquinolines using this 
procedure, the advantages of which include easy handling of reagents, which have low 
12 
toxicity, and the employment of mild conditions. This ISB methodology will be hopefully 
applied to other BBIQ syntheses. 
1.6 Tetrahydroisoquinoline Ring Closure 
The Bischler-Napieralski reaction52 is of great importance in isoquinoline 
synthesis. This reaction was employed for the construction of isoquinoline rings during 
the original syntheses of BBIQs. An endocyclic iminium ion is formed under the classic 
Bischler-Napieralski reaction conditions of refluxing an amide and a Lewis acid (such as 
POCh) in benzene. The iminium ion is subsequently reduced by NaB& to give the 
isoquinoline ring. 
This currently accepted mechanism, outlined in Scheme 4, was first proposed by 
Fodor and Nagubandi53 in 1980. The Lewis acid initially coordinates with the carbonyl 
oxygen of the amide 28 and forms the intermediate 29. Electrophilic attack by the 
aromatic ring and subsequent re-aromatization results in the formation of the 
/OX)) POCl3 /om /0~ 
'-o """- lo~NR .. I • .. 'o ~ RJ{JR ........._ ~ NR 
O ~ H OPOC12 
R OPOC12 Cl- R 
28 29 30 
~ /ox:Q /xq ~ I +NR • ~ I -c:·NR 
'o 'o ~POClz 
R R 
32 31 
Scheme 4. 
13 
tetrahydroisoquinoline intermediates 30 and 31. The resultant iminium ion 32 is reduced 
to the corresponding tetrahydroisoquinoline by sodium borohydride. 
The presence of an electron-donating group para to the site of the ring closure is 
necessary for the BNC reaction to occur. As a result, there may be more than one ring-
closure site if there are two or more electron-donating groups. As well, a bulky group 
may block ring-closure on a position ortho to that group. 
Pictet-Spengle~4 and Pomeranz-Fritsch cyclizations55 have also been employed to 
construct the six-membered ring. The Pictet-Spengler cyclization has become the most 
popular method for the construction of six-membered heterocyclic rings because of 
several advantages, such as the use of milder reaction conditions than the traditional BNC 
reaction and also the lack of a requirement for a subsequent reduction. Unfortunately, the 
application of Pictet-Spengler cyclization methodology in an earlier attempt of the 
synthesis of cycleanine by M. Ralph in the Georghiou laborator/6 was abandoned due to 
the failure to obtain the necessary precursor needed for the cyclization step. 
This thesis will describe approaches applied towards the isoquinoline ring closure 
using BNC methodology. The utilization of a chiral auxiliary to control a chiral centre 
outcome of a ring-closure step will also be discussed. 
1.7 Diaryl Ether Formation 
Diaryl ethers are an important class of compounds in pharmaceuticals and organic 
natural products. A large variety of naturally-occurring and medicinally-important 
compounds contain a diary I ether moiety. Among the methods used for the preparation of 
such diaryl ethers, the classic Ullmann57 ether synthesis is the most well known. 
14 
However, this reaction, in which an aryl bromide or iodide reacts with a phenol under 
basic conditions in the presence of copper salt catalysts, is often limited by the need to 
employ harsh reaction conditions and stoichiometric amounts of copper. 57 Ar... 
improvement to the classic Ullmann ether synthesis has been reported by Buchwald. 58 
Recent developments in palladium-catalyzed ether formation reactions have solved 
certain problems in this area as well. 53 However, at present, copper catalysts still play an 
important role in industrial applications because of the advantage of their low cost in 
large-scale reactions. 
According to Evans,36 the addition of powdered 4 A molecular sieves to the 
reaction mixture was confirmed to suppress phenol and diphenyl ether formation and 
increase product yields. It was further noted that a dry and pure oxygen atmosphere was 
unnecessary, as running the reaction under an ambient condition gave identical results. 
Although evidence is lacking, the base, triethylamine or pyridine, could have a dual role 
as both a base and a ligand for the organocopper intermediates. From Evans' 
observations, pyridine increased the yield of this transformation. Although further studies 
on the mechanism of this methodology are ongoing, Evans36 put forth the following 
preliminary hypothesis. The boron-metal exchange of arylboronic acid 33 with copper 
acetate can afford arylcopper(ll) complex 34, which reacts with phenoxide ion to form 
the corresponding arylcopper(ll) phenoxide intermediate 35. This arylcopper(ll) 
phenoxide intermediate 35 can undergo either subsequent reductive elimination to the 
diaryl ether compound 37 or oxidation to arylcopper(ill) phenoxide intermediate 36 prior 
to elimination to produce product 37 as shown in Scheme 5. 
15 
L 
B(OH>2 11bu/L 
R- AcO-Cu(II)-OAc 1 ~ \ R-
boron-metal mhango ~ OAo 
33 34 AI()-
37 
.~ 
R-
'u 
L 
11 1 /L Cu 
\ 
OAr 
35 
reductive elimination f 
02 L 
lll bu/L 
L'Y\ 
R-v- OAr 
36 
Scheme 5. 
Evans36 and Chan37 explored the use of arylboronic acids to couple with activated 
phenols through the mediation of Cu(0Ac)2. A number of structurally and electronically 
diverse substrates were evaluated by Evans36 and Wang. 59 It can be seen from Table 2, 
that electron-rich phenols underwent arylation most efficiently. Evans also pointed out 
that generally ortho-substituted phenols were arylated in good yields, but that yields were 
depressed with ortho-substituted boronic acids. 
Approaches towards the total syntheses of (-)-cycleanine, isoquinolones and 
related structures using recently developed methodologies are discussed in this thesis. 
The Cu(OAc)2-mediated diaryl ether formation methodology, which was employed to 
furnish the diaryl ether ring-closure step, will be discussed in detail. The use of a chiral 
auxiliary-assisted diastereoselective Bischler-Napieralski cyclization strategy will be also 
studied in the following section. 
16 
Table 2. Cu(OAch-mediated diaryl ether formation 
Phenol 
38 
0 
H~ 
41 
44 
Boronic acid 
BoO~ 
~OTBDMS 
(H0)2B 
OH 
39 
""OM 
(H0)2B I # R 
OH 0 
42 R= / "'-./0 -....... 
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CHAPTER2 
Synthetic Efforts towards (-)-Cycleanine 
2.1 Introduction 
This chapter is focused on the synthesis of (-)-cycleanine (8). As described in 
Chapter 1, (-)-cycleanine (8) has a C2-symmetric structure connected "head-to-tail" by 
two diary! ether linkages. Because of cycleanine's particular structure and especially its 
pharmacological activities, 15• 39 the total synthesis of this BBIQ alkaloid is attractive to 
both organic chemists and pharmacognosists. However, an enantioselective synthesis of 
this natural compound has not yet been accomplished. Most of the previous attempts 
towards this target have been attributed to Tomita et al. 26-29 Based on retrosynthetic 
analysis of (-)-cycleanine and Tomita's synthetic experience, several multistep routes 
were evaluated towards the target molecule and are described in this thesis. 
2.2 Results and Discussion 
2.2.1 Initial Proposal For the Synthesis of (-)-Cycleanine 
Outlined in Scheme 6 is an initial retrosynthetic analysis for (-)-cycleanine (8). 
The first retrosynthetic cut gives the chiral-auxiliary (CA)-protected boronic acid 56 as a 
precursor to the Cu(pAc h-promoted ether coupling step, which is one of the main 
methodologies applied in this synthesis. In the synthetic direction, BNC of amide 57 
would be expected to result in the formation of boronic acid 56 and its regioisomer 
because there are two sites for the ring-closure step (para and ortho to the electron-
donating benzyloxy group). Structure 57 includes boronate, chiral auxiliary and amide 
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moieties required for the ring-closure step to the corresponding isoquinoline 56. A 
further retrosynthetic cut dissects the amide 57 into the key intermediates: chiral amine 
58 and carboxylic acid 59. These two key intermediates are required for the Schotten-
Baumann reaction60 to afford the amide 57. At this initial synthetic stage, the synthesis 
was reduced to the formation of those four key intermediates: boronic acid 56, boronate 
57, chiral amine 58 and carboxylic acid 59. 
Cu(O~-mediated ether coupling 
I 
' H3CO 
'-- Cu(OAch-mediated ether coupling 
Cycleanine (8) 
58 59 
Scheme 6. 
56 
D 
CCC~, 
B(OHn 
11\t.~ ·~, 
1 \U/a 
Schotten-Baumann 1- -K 
Reaction 57 ~ 
In Chapter 1, an alternative ring-closing methodology investigated in the 
Georghiou laboratory for the formation of the isoquinoline rings was discussed and no 
satisfactory results were obtained. 56 On the other hand, other methods of ether formation, 
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including the classic Ullmann coupling, 57-58 were not considered in this particular 
synthesis due to the disadvantageous reaction conditions which these methods require. In 
this thesis, discussion will concentrate on the Cu(0Ac)2-mediated boronic acid coupling 
methodology first described by Evans36 and Chan.37 In addition, the use of a chiral 
auxiliary-assisted BNC required for the cyclizaton of 57, will also be examined. 
The effects of some substitutents on the ring-closure step needed to construct 
compounds 56-59 will also be presented. The role of a chiral auxiliary in controlling the 
stereoselectivity will be another key point in the following sections. Furthermore, 
suggested alternative attempts towards the completion of the target molecule will be 
explored. 
2.2.2 Model Study of Diaryl Ether Formation 
As described in Chapter 1, the diaryl ether formation methodology was employed 
in the synthesis of (-)-tejedine (9).34 The model study of this methodology was explored 
in the Georghiou laboratory, and it is displayed in Table 2 of Chapter 1. Under diaryl 
ether formation conditions, only those reactions between boronic acids and ortho-
substituted phenols afforded the corresponding diaryl ethers with acceptable yields. The 
yields were very low with ortho-substituted boronic acids, as was noted by Evans.36 
When pyridine was the base in these model studies, good yields were obtained. When 
triethylamine was used as the base, very low yields were obtained. Furthermore, very 
dilute solutions (0.05 Min reaction solution) were found to be necessary for the diaryl 
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ether formation to occur efficiently. As described in Evans' report, 36 4 A molecular 
seives were added to the reaction and this helped to increase the reaction yields. 
2.2.3 Synthesis of the Key Intermediates 56-58 
Vanillin (23) was chosen as the starting material for the synthesis of chiral amine 
58 since vanillin has substituent groups that are suitable for further functionalization. 
Protection and deprotection of those functional groups are necessary in this synthesis. 
The chosen protecting groups should withstand the reaction conditions without 
H~OC-H-3~a~~~H 
UOH 
0 0 
H 
b 
Br Br 
Vanillin (23) 60 61 
!' 
TBSO~OCH ..... 3...,_;:e;....__TBSO~OCH3~-d--HO~OCH, 
~OCH3 ~OCH3 ~OCH3 
OH Br Br 
64 63 62 
NaBH4, MeOH, THF, 99%; d) TBSCI, imidazole, DMF, rt., 88%; e) l. t-BuLi, then B(OMe)); 2. 
-78°C, H20 2• 71 %. Scheme 7. 
interference with other substituent groups. At the same time, those protecting groups 
should be easily removed at a later stage. Considering the above, the synthetic routes 
shown in Schemes 7-10 were designed towards those intermediates. 
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Because of the ortho-directing effect of the hydroxy group on vanillin, the 
first bromination step gave the desired 5-bromovanillin 60 (95%). Methylation of 60 
furnished 5-bromoveratraldehyde 61 (85%). Reduction of the aldehyde moiety of 61 
using NaB~ afforded a primary alcohol 62 (99%). Protection of the hydroxy group in 62 
as the TBS ether 63 (88%) was followed by a lithiation-boronation sequence, involving 
by quenching with trimethyl borate at -78 °C and finally oxidation using hydrogen 
peroxide. This resulted in formation of the phenol 64 (71 %). 
After these five straightforward steps, phenol 64 was converted to the 
phenylacetic acid 69 in very high overall yields (68%). Protection of the phenol 64 as a 
benzyl ether 65 was followed by easy removal the TBS group using TBAF to afford the 
primary alcohol66 (99%). Reaction of 66 with thionyl chloride produced the chloride 67 
in almost quantitative yield. Cyanation gave compound 68 (91% ), which was followed by 
hydrolysis with NaOH/EtOH to form the phenylacetic acid 69 (90%). Studies in the 
Georghiou laboratory by Dr. Wang found that the commercially available (R)-(+)-a-
methylbenzylamine to be the most efficient chiral auxiliary to affect a diastereoselective 
BNC at later steps. A detailed discussion of this reaction will be presented in later 
sections of this thesis. Reaction of the phenacyl chloride, formed in situ from 
phenylacetic acid 69, with (R)-(+) -a-methylbenzylamine under Schotten-Baumann 
conditions resulted in the formation of amide 70 (85%), which was reduced to the 
corresponding chiral amine 58 upon treatment with BH3/THF and BF3/Et20 in refluxing 
THF. The Schotten-Baumann reaction was employed in this research as the main 
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OBn 
r 69R=OH 
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OMe 
OBn 
65 
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CI 
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OMe h 
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OMe 
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67 
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Conditions: a) BnBr, K2C03, acetone, 85%; b) TBAF, THF, 0 °C, 99%; c) SOCI2, benzene, 98%; d) 
NaCN, DMSO, benzene, 91 %; e) 4.0 M NaOH, ethanol, reflux, 90%; f) (COCI)z, benzene, DMF; g) 69a, 
(R)-( + )-a-methylbenzylamine, 5% Na0H-CH2Cl2, 84%; h) BH3ffHF, BF3IEtzO, THF, reflux, 81%. 
Scheme 8. 
method to construct target amides. 
Attention was next directed towards the construction of the key intermediate 59. 
The synthesis of 59 is shown in Scheme 9. This synthesis started from 4-hydroxy-
phenylacetic acid 71, which is commercially available. Esterification of the carboxylic 
acid in refluxing methanol in the present of a catalytic amount of concentrated sulfuric 
acid gave methyl(4-hydroxyphenyl)acetate 72 (91 %). According to published reports, 61 
activation of the phenolic group is necessary prior to the palladium-catalyzed borylation 
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step. Reaction of 72 with Tf20 at -40 °C in the presence of 2,6-lutidine converted 
a b 
OH OH OTf 
71 72 73 
0 0 
d 
#r~ 
75 ~' 59 
Conditions: a) MeOH, cone. H2S04, reflux, 90%; b) Tf20, 2,6-lutidine, CHzClz, -40 °C, 83%; 
c) 74, PdCI2(dppf), Et3N, dioxane, 80 °C, 75%; d) LiOH, THF-MeOH-H20, 95%. 
Scheme 9. 
the phenolic group to the triflate 73, in good yield (83%). [1,1'-Bis-
( di ph en ylphosephino )-ferrocene ]dichloropalladi um(II) (PdC12( dppf) )-catalyzed coupling 
of triflate 73 with bis(pinacolato)diboron 7462 afforded the boronate acetate 75. In order 
to increase the yield from this step, the reaction was repeated under different conditions. 
Refluxing of the reactants for 5 h at 80 °C in dioxane in the presence of the catalyst with 
triethylamine as a base was found to be the best set of conditions, the yield being 
75%. Hydrolysis of acetate 75 using aqueous lithium hydroxide afforded the key 
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CQ:OMe N 
OMe 
a 
OBn b 
l~ 
59 57 
c 
Conditions: a) (COCI)z, benzene, 58, aq. 5% NaOH-CH2C12, 89%; b) POCI3, benzene, reflux; c) NaBH4, MeOH, 
-78 °C, 88% from 57. 
Scheme 10. 
carboxylic acid 59 (95% ). 
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With the two intermediates 58 and 59 on hands, application of Schotten-
Baumann reaction conditions smoothly afforded in 89% yield (Scheme 10) amide 57. As 
discussed in Chapter 1, the BNC reaction was used to carry out the ring-closure step. 
Because there are two possible ring-closure sites on the precursor amide 57, para and 
ortho to the benzyloxy group, the BNC step would be expected to proceed via a pair of 
ring-closure products 76a and 76b. 
Normal BNC conditions, refluxing the amide 57 with phosphorus oxychloride in 
anhydrous benzene, resulted in the formation of the iminium salts 76a and 76b. These 
compounds were reduced by using NaBH4 to afford a pair of regioisomers 77a and 77b. 
The chiral auxiliary directed the formation of the new chiral center in these compounds. 
Presumably, hydride adds to the double bond of the iminium salts 76a (and 76b) from the 
less hindered face in the reduction step. This would be due to the steric hindrance 
presented by either the methyl or phenyl group of the chiral auxiliary moiety. Difficulties 
encountered in separating this pair of regioisomers prevented confirmation of this 
hypothesis. However, the X-ray crystal structure (Figure 2) of a similar ring-closure 
product 85a at a later stage, clearly established the configuration of the chiral centers in 
85a, and established that the configuration of the new stereo genic center was the desired 
one. 
The use of either flash column chromatography or preparative layer 
chromatography did not lead to separation of these regioisomers. As a result of this 
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difficulty, subsequent research was continued using the mixture of regioisomers. 
In order to obtain a boronic acid from the corresponding boronate, Jung and 
Lazarova's63 procedure can be applied: reaction of a boronate ester with diethanolamine 
forms the corresponding cyclic aminoboronate intermediate, which is hydrolyzed in situ 
to give the boronic acid. The above procedure was applied in this research, but it gave a 
very low yield. In the meantime, an efficient procedure for the same conversion, which is 
called "trans-hom-esterification" with phenyl boronic acid and treatment with aqueous 
OMe OMe OMe 
OMe OMe OMe 
a • b 
r~ B(OH}z B(OH}z 77a(b) 78a(b) 79a(b) 
* 
d (-)-cycleanine (8) -.. - - - - - · 
80 
Conditions: a) phenylboronic acid, aq. 2.0 M HCl, THF, MeOH, 70%; b) H2, Pd/C. EtOH-EtOAc-aq. 10% HCl; 
c) Cu(OAch. pyridine, 4 A molecular sieves, CH2Cl2 ; d) aq. 37% HCHO, NaBH3CN. 
Scheme 11. 
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2.0 M HCl, was reported by Decicco.64 This procedure was employed to bring about 
the conversion of boronates 77a(b) to the mixture of corresponding boronic acids 78a(b) 
(70% ). The conversion of only one regioisomer 77a is shown in Scheme 11. Palladium-
catalyzed hydrogenolysis smoothly removed in one step both the chiral auxiliary and the 
benzyl group of the boronic acid 78a. Since 78a could not be separated from 78b, the 
mixture of phenolic compounds 79a(b) was used in the homocoupling reaction step. 
Using the Cu(OAc)z-mediated coupling reaction conditions, with a stoichiometric 
amount of Cu(OAc)z, a catalytic amount of pyridine, and 4 A molecular sieves in very 
dilute solution (5.0 x 10-3 M solution in CH2Ch), the first coupling attempt did not afford 
80. This is likely because the precursors to the coupling reaction product were a mixture 
of regioisomers, which should result in the formation of at least four coupling products. 
Another problem experienced was that the precursor compounds possess a tertiary amine 
group, a phenolic group and a boronic acid group all of which are polar. As a result, it 
was very difficult to monitor the reaction. 
Although the first attempt was not successful, some important information and 
experience were gained. First, in order to establish the configuration of the ring-closure 
product isoquinoline 77a, the separation and the purification of the pair of regioisomers 
77a and 77b is necessary. Second, suitable modification of the precursor to the final 
coupling step may be required. For example, the use of a less polar precursor, such as a 
protected tertiary amine, could increase the success of the coupling reaction. In addition, 
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because difficulties were experienced in the separation of these regioisomeric 
compounds (77a(b), 78a(b) and 79a(b))~ and because these compounds were not easily 
prepared on a large scale, the chemistry of these compounds was not explored any 
further. Similar, but modified, compounds were more fully investigated instead, and these 
investigations are described in later sections. 
2.2.4 First Modified Synthetic Route towards (-)-Cycleanine 
As a result of our initial findings, the synthetic route was modified as shown in 
Scheme 12. This route is similar to the initial retrosynthetic route, but with two important 
differences. An iodine atom was used instead of the boronate moiety in target 
intermediates 81 and 82, which potentially allowed the formation of the boronic acid in a 
later step. It was hoped that without the boronate moiety present, the regioisomers that 
resulted from the BNC step might be separated more easily. Furthermore, a tert-
butoxycarbonyl (Boc) group-protected tertiary amine 56a should be less polar than the 
methylated tertiary amine 56, which could assist the workup step in the subsequent 
cyclization reaction. 
The next focus was the construction of the key intermediates 56, 56a, 81 and 
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Schotten-Baumann Reaction 
81 
82. The synthesis of the chiral amine 58 had already been completed in the previous route 
(Scheme 7). As shown in Scheme 13, the carboxylic acid 82 could be easily constructed 
from 4-iodobenzylchloride 83 via two straightforward steps. Cyanation of 83, followed 
by hydrolysis in aqueous 4.0 M NaOH afforded the carboxylic acid 82 in good yield 
(84% ). It should be mentioned that 4-iodobenzyl chloride 83, which was synthesized by 
the Georghiou laboratory via a two-step sequence, can be easily produced from 4-
iodobenzaldehyde, a commercially available reagent. Reduction of 4-iodobenzaldehyde 
using NaB~ afforded a corresponding primary alcohol, which was chlorinated using 
SOCh to form 83 in situ. 
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Under Schotten-Baumann reaction conditions, 82 was reacted with the chiral 
amine 58 to form the amide 81 (98% ), the precursor required for the BNC reaction. 
Amide 81 existed as slowly interconverting rotamers and exhibited its clearest 1H NMR 
_a~NC~ 
I 
83 84 
Conditions: a) NaCN, DMSO, benzene, 85%; b) aq. 4.0 M NaOH, EtOH, 84%. 
Scheme 13. 
spectrum at 100 °C (the compound decomposed above 100 °C). At this temperature most 
of the protons appeared as single sets of signals. 
An efficient route for the formation of the isoquinoline regioisomers 85a(b) under 
BNC reaction conditions is shown in Scheme 14. Cyclization of amide 81 under such 
conditions with POCh in benzene was followed by N aBI4 reduction, which afforded a 
pair of regioisomers 85a and 85b in 37 and 40% yields, respectively. At this stage, the 
pair of regiosomers was successfully separated by flash chromatography and crystals of 
85a suitable for X-ray crystallography were obtained. The regioisomer 85a, which was 
required for the synthesis of (-)-cycleanine, was formed in approximately> 90% de, as 
estimated from its 1H NMR spectrum. 
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0 
a 85a 
82 81 
85b 
Conditions: a) (COCI)z, benzene, then 58, aq. 5% NaOH-CH2CI2, 98%; b) 1). POCl3, benzene, reflux; 2). 
NaBHa. MeOH. -78 °C; 37% for 85a; 40% for 85b. 
Scheme 14. 
Due to the known R-configuration of the chiral auxiliary, the X-ray crystal 
OMe 
OMe 
OBn 
OMe 
structure65 (Figure 2) of 85a could be used to establish that the absolute configuration of 
the new stereogenic center was the desired one. Unfortunately, efforts towards obtaining 
suitable crystals of 85b for X-ray crystallography were not successful. The 1H NMR and 
NOED spectra of 85a/85b were also consistent with the proposed structures obtained 
(Figure 3). From their 1H NMR and NOED spectra, two significant differences between 
the two compounds 85a and 85b were clearly identified. 
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Figure 2. ORTEP Representation of Compound SSa 
First, in the 1H NMR spectrum, the signals for Hb and Hb' (diastereotopic) of the 
benzyl group of SSa were observed as a well-separated pair of doublets at 8 5.20 and 4.20 
(1 = 9.7 Hz). The corresponding protons of compound SSb, however, appeared as a triplet 
(AB system, J AB=5.4 Hz). Second, for compound SSa, a NOE could be detected between 
the aromatic proton Ha and the protons He on one of the methoxy groups, but no NOE 
effect could be observed between the aromatic proton Ha and the protons Hb and Hb' on 
the benzyl group. However, for compound SSb, the only NOE observed was that between 
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the aromatic proton Ha and the protons Hb and Hb' on the benzyl group, and no 
NOE was observed between the Ha and the protons He on the methoxy group. 
8Sa 8Sb 
Figure 3. Structures of 85a and 85b 
With enantiomerically pure iodotetrahydroisoquinoline 85a in hand, the 
conversion to its corresponding boronate 77a and the boronic acid 56 was attempted. The 
procedure that was first attempted for this transformation was a modification of the 
procedure of an iodine-magnesium exchange reaction reported by Knochel. 66 In his 
report, transmetallation with a Grignard reagent followed by quenching with trimethyl 
borate and then hydrolysis with aqueous HCl accomplished the conversion from an 
iodide to its corresponding boronic acid. However, the same iodine-magnesium exchange 
procedure (Scheme 15) applied in this research failed to convert 85a into 78a. 
Surprisingly, all of the starting material was recovered. 
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OMe OMe 
OMe ><. OMe 
B(OH)2 
8Sa 78a 
Condition: 1). i-PrMgCI!fHF, -60 °C to -40 °C; 2) B(OMe)), -50 °C to -60 °C; 3). aq. 2.0 M HCI, H20. 
Scheme 15. 
Based on this, a combination of PdCh(dppf)-catalyzed borylation and the 
subsequent trans-bora-esterification reported by Decicco64 was employed to complete the 
formation of boronic acid 56 in two steps (Scheme 16). The first step resulted in the 
formation of the corresponding boronate 77a and the second step efficiently completed 
the construction of the boronic acid 56, a key precursor of the next homocoupling step, as 
well as simultaneously removing the benzyl group of 77a to form the phenolic group. 
However, the subsequent homocoupling reaction of the boronic acid 56 in the presence of 
Cu(OAc )z was not successful, and the mass spectrum of the resulting product mixture 
was inconclusive. No additional spectroscopic evidence could be obtained because of an 
insufficient quantity of the sample. 
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OMe OMe OMe 
OMe a OMe b 
OMe 
B(OH)z 
85a 
. 8 d (-)-cyclearune ( ) ~-----
Conditions: a) PdCJ2(dppf), DMSO, KOAc, 74, 68%; b) phenylboronic acid, cone. HCI (aq.), MeOH, reflux, 68%; 
c) Cu(OAch. pyridine, 4 A molecular seives; d) 1. H2, Pd/C; 2. HCHO, MeCN, NaBH3CN. 
Scheme 16. 
Another strategy towards (-)-cycleanine involved producing the Boc-protected 
amine 56a as the precursor to the coupling step (Scheme 17). However, the synthesis of 
56a could not be achieved. Palladium-catalyzed hydrogenolysis removed the chiral 
auxiliary group to afford the tertiary amine 79a. It was hoped that this could be protected 
with a Boc group to form the carbamate 56a. The tertiary amine 79a, however, was 
difficult to purify due to the polarity of the compound, and as a result, unequivocal 
formation of the desired carbamate was not achieved by this route. The synthetic scheme 
envisioned in Scheme 17 was therefore abandoned. 
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Conditions: a) H2, Pd/C, EtOH-EtOAc-aq. 10% HCI; b) Boc20 , THF, Et3N, -78 °C tort.; c) Cu(OAc)z, 
pyridine, 4 A, CH2Cl2; d) I . TFA, THF; 2. HCHO, MeCN, NaBH3CN. 
Scheme 17. 
2.2.5 Second Modified Synthetic Route towards (-)-Cycleanine 
All of the previous efforts towards the target molecule were based on a 
OMe 
OMe 
B(OHh 
homocoupling of an isoquinoline subunit precursor. Although the enantiomerically pure 
isoquinoline subunits were obtained, the key coupling step of these subunits using the 
Cu(OAc)z-mediated diaryl ether formation methodology remained unsuccessful. 
Considering the polarity of the precursors and the requirements for the coupling reaction 
conditions, such as the concentration of the reactants, the length of reaction time and even 
the molar ratio among those reactants, the two diaryl ether linkages are difficult to form 
in such a coupling reaction. In addition, the possibilities that not just the single desired 
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diaryl ether linkage could be formed, but that also other undesired ether linkages 
could be formed between the isoquinoline subunits made the coupling reaction even more 
potentially complex. Thus, a different synthetic route was proposed for the synthesis of 
(-)-cycleanine. The retrosynthetic analysis of this new approach is outlined in Scheme 
18. Based on this retrosynthetic analysis, the formation of the two precursor subunits 78a 
Cu(OAch-mediated ether coupling 
r--
1 
OMe 
OMe 
90 
+ 
OMe 
OMe 
, H3CO 
'--Cu(OAch-mediated ether coupling 
B(OHn 
78a 
Scheme 18. 
and 90 was explored. From previous efforts (Scheme 11), it was found that 78a can be 
produced from the corresponding boronate tetrahydroisoquinoline 77a via a trans-boro-
esterification with phenyl boronic acid and aqueous 2.0 M HCI. Thus, this new approach 
focused on the formation of the other key intermediate 90. Unfortunately, methylation of 
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the tertiary amine 91a failed (Scheme 19), perhaps for the same reason(s) that led to 
the failure to obtain the Boc-protected tertiary amine 56a (Scheme 17). However, 
although the methylation or Boc-protection of the tertiary amine steps failed in the hands 
of this author without further exploring the reaction conditions, it is felt that this stepwise 
diary! ether formation proposal is still viable, and needs further study. 
OMe OMe OMe 
OMe OMe OMe 
a 
* 
77a r~ 91a r~ 90 
Conditions: a) H2, Pd/C, EtOH-EtOAc-aq. 10% HCI; b) HCHO, MeCN, NaBH3CN. 
Scheme 19. 
2.3 Summary 
Although the goal of completing the total synthesis of (-)-cycleanine (8) was not 
achieved, the information presented in this thesis does offer promise for future 
endeavours. The difficulties experienced in the synthetic efforts have been discussed. 
Such information could lead to the modification of existing synthetic proposal, thus 
providing a important foundation for future success. 
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2.4 Experimental 
General 
Flash column chromatography was performed using 240-400 mesh silica! gel and 
preparative layer (1 mm) chromatography (PLC) was conducted using 60 mesh silica gel. 
All solvents and reagents used were either of the highest commercial grade available/or 
were redistilled (CH2Ch, hexane, and benzene distilled over CaH2, CHCb distilled over 
P40 10). 1H and 13C NMR spectra were obtained on a General Electric GE-300 NB 
spectrometer at 300 MHz in CDCb unless otherwise specified, and shifts are relative to 
an internal trimethylsilane signal. Some of the NMR data were obtained on the Bruker 
Advance 500 MHz instrument with a TXI inverse-detect gradient probe and these data 
are designated in the experimental section. The following abbreviations are used in 
description in the 1H NMR: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet) 
and b (broad). The 13C NMR spectra shifts were measured relative to the solvent. Overlap 
may have prevented the reporting of all resonances when the spectral data of compounds 
were obtained from mixtures. NMR free induction decay data were processed using 
WinNuts (Acorn NMR software). Low-resolution mass spectral data were obtained from 
the V.G. Micromass 7070HS instrument or obtained from Atmospheric Pressure 
Chemical Ionization-Mass Spectrometry (APCI-MS). Mass spectral data and intensity 
(%) are described as MS (mlz) unless mass data obtained from Atmospheric Pressure 
Chemical Ionization-Mass Spectrometry (APCI-MS), which are described as APCI-MS 
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(mlz). Melting points (m.p.) were determined using a Fisher-Johns hot stage apparatus 
and are uncorrected. 
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1-(R)-( 4-Dihydroxyborylbenzyl)-N -[ (R)-a-methylbenzyl]- 6, 7 -dimethoxy-8-hydroxy-
1,2,3,4-tetrahydroisoquinoline (56) 
To a solution of 77a (47 mg, 0.076 mmol) in THF (6.0 mL), 
were added MeOH (2.0 mL), aqueous concentrated HCl (9.4 
mL) and phenylboronic acid (19 mg, 0.16 mmol). After 
refluxing for 6 h, the solvent was removed by a rotary 
evaporator and the resultant mixture was neutralized by 
B(Olfh 
using 6.0 M NaOH (3.0 mL) and aqueous saturated NaHC03 (5.0 mL) subsequently. The 
mixture was added EtOAc (15 mL) and transfer to a separatory funnel. The aqueous 
layers were re-extracted with EtOAc (10 mL x 3) and the combined organic layers were 
washed with water (10 mL), dried over MgS04, filtered, and the solvent was evaporated 
in vacuo. The residue was redissolved in CH2Ch and purified with preparative 
chromatography (10% MeOH/CH2Ch) to afford 56 (27 mg, 68%) as a colorless oil; 1H 
NMR (500 MHz): 8 8.16-5.78 (m, lOR, Ar-H), 4.05 (m, lH, H-3), 3.91 (s, 3H, OCH3), 
3.88 (s, 3H, OCH3), 3.66 (m, lH, H-a), 3.47 (m, lH, H-3), 3.30 (m, lH, H-4), 3.04 (m, 
lH, H-4), 2.90 (m, 2H, H-a), 2.41 (m, lH, H-1), 1.24 (m, 3H, H-(3); APCI-MS (mlz): 
448.20 ~ +2, 26), 420.20 (100). 
N -( (R)-a-Methylbenzyl)-N -( (3-benzyloxy-4,5-dimethoxy )phenethyl)-( 4-( 4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl) ]phenylacetamide (57) 
To a stirred solution of oxalyl chloride (0.070 mL, 0.40 mmol) in anhydrous benzene (10 
mL) were added 59 (76 mg, 0.29 mmol) and DMF (3 drops). The mixture was stirred 
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until the evolution of gas ceased. The benzene was then 
evaporated to give crude acid chloride, which was used 
directly in the next step. 
The acid chloride was re-dissolved in CH2Ch (10 mL) at 
0 °C. To this solution, a stirred mixture of 58 (110 mg, 
0.29 mrnol) and CH2Cl2-aqueous 5% NaOH (1:1.5, 5.0 
rnL) was added. After stirring at room temperature for 1 h, the reaction mixture was 
extracted with chloroform (5.0 rnL x 3), washed with water (5.0 rnL x 2), dried over 
anhydrous MgS04, filtered, and the solvent was evaporated. The residue was purified by 
flash column chromatography (30% EtOAc/hexane) to afford amide 57 (170 mg, 89%) as 
a viscous oil; 1H NMR (500 MHz, toluene-d8, 373 K): 8 6.96-7.91 (m, 14H, Ar-H), 6.27 
(s, 1H, H-2), 6.19 (s, 1H, H-6), 4.89 (s, 2H, H-a"), 3.74 (s, 3H, OCH3), 3.63 (m, 3H, H-
a", H-a"), 3.52 (s, 3H, OCH3), 3.21 (m, 2H, H-a), 2.59 (s, 1H, H-{3), 2.30 (s, 1H, H-{3), 
1.25 (d, 1=6.4 Hz, 3H, f3"-CH3), 1.15 (s, 12H, CH3); APCI-MS (mlz) 636.35 (~+2, 100). 
N -( (R)-a-Methylbenzyl)-(3-benzyloxy-4,5-dimethoxy )phenylacetamine (58) 
ft 1 6 OCH To a solution of chiral amide 70 (180 mg, 0.45 mrnol) in a. ~ 3 
H 3 OCH3 
:1 00, 
~I 
~ 
0.20 mrnol) under argon. The mixture was heated to gentle 
reflux and BH:IfHF (1.0 M solution in THF, 1.3 rnL, 1.1 
mrnol) was then added dropwise. The reaction mixture was 
refluxed for 2 h, and then the reaction mixture was cooled to 0 °C and aqueous 20% HCl 
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(20 mL) was added to the mixture. The reaction which was stirred at 0 °C for 1 h and then 
at room temperature overnight, was basified to pH =13 with aqueous 50% KOH solution. 
The mixture was then extracted with CH2Ch (10 mL x 3). The combined organic layers 
were washed with water (20 mL x 3), dried over anhydrous MgS04, filtered, and the 
solvent was evaporated to afford 58 (140 mg, 81 %) as a colorless oil, which was pure 
enough to be used directly in the next step; 1H NMR: 8 7.58-7.36 (m, 10H, Ar-H), 6.55 
(d, 1=1.6 Hz, 1H, H-2), 6.50 (d, 1=1.6 Hz, 1H, H-6), 5.08 (s, 2H, H-a'), 3.85 (s, 3H, 
OCH3), 3.81 (s, 3H, OCH3), 3.74 (m, 1H, H-a"), 2.69 (m, 4H, H-a, H-l3), 1.32 (d, 1=6.5 
Hz, 3H, H-13"); APCI-MS: 392.20 (W+1, 100). 
4-( 4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenylacetic acid (59) 
To a solution of 75 (160 mg, 0.59 rnmol) in MeOH-THF-H20 
o~ (5.0 mL, 1:3:1) was added powdered LiOH (36 mg, 1.5 
3 I 
~ 4 B....._o mmol). The reaction mixture was stirred at room temperature 
for 2 h. The reaction was quenched with water, neutralized 
0 
with aqueous 10% HCI and extracted with CH2Ch (10 mL x 
3). The combined organic extracts were washed with brine (2 x 5.0 mL), dried over 
MgS04, filtered, and the solvent was evaporated. A white foam was obtained which was 
purified by preparative TLC (50% EtOAc/hexane) to give 59 (150 mg, 95%) as a white 
powder; 1H NMR (500 MHz): 8 7.79 (d, 1=7.6 Hz, 2H, H-2, H-6), 7.30 (d, 1=7.6 Hz, 2H, 
H-3, H-5), 3.67 (s, 2H, H-a), 1.33 (s, 12H, CH3); 13C NMR: 8 175.4, 136.6, 135.3, 128.9, 
84.0, 69.3, 41.1, 25.1; MS (m/z): 261 (W, 34), 247 (46), 163 (100), 91(16). 
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3-Bromo-4-hydroxy-5-methoxybenzaldehyde (60) 
H Bromine (11 mL, 0.22 mol) was added dropwised to a solution of 
vanillin 23 (30 g, 0.20 mol) in glacial acetic acid (1 00 mL). After 
OH 
Br stirring for 1 h, the reaction mixture was diluted with ice-water ( 400 
mL), the resulting precipitate was filtered, washed with water (50 mL 
x 2), and dried over P20s under reduced pressure to give 60 as a colorless solid ( 44 g, 
95%); m.p. 162.0-162.5 °C (Lit.,67 m.p.164-166 °C.); 1H NMR: 8 9.79 (s, 1H, CHO), 7.65 
(d, J=1.8 Hz, 1H, H-2), 7.37 (d, J=1.8 Hz, 1H, H-6), 6.57 (s, 1H, OH), 3.99 (s, 3H, 
OCH3). 
3-Bromo-4,5-dimethoxybenzaldehyde (61) 
H A mixture of60 (44 g, 0.19 mol), sodium hydroxide (20 g, 0.50 mol), 
Br 
dimethyl sulfate (30 mL, 0.18 mol), Adogen 464® (5.0 mL), water 
(350 mL) and CH2Ch (350 mL) was vigorously stirred at room 
ocH3 temperature. After 16 h, the organic layer was separated and the 
aqueous layer was extracted with CH2Ch (1 00 mL x 2). The combined CH2Ch extracts 
were thoroughly washed with aqueous ammonium hydroxide (30 mL of 30% NH3 (aq.) 
diluted to 100 mL with water), water (100 mL), dried over MgS04, filtered, and the 
solvent was evaporated to give an oily residue. The residue was purified by flash column 
chromatography (10% EtOAc/hexane) to afford 61 as a colorless solid (39 g, 85%); m. p. 
62-63 °C.(Lit.,68 m.p. 63-64 °C.); 1H NMR: 8 9.85 (s, 1H, CHO), 7.65 (d, J=1.9 Hz, 1H, 
H-2), 7.39 (d, J=l.9 Hz, 1H, H-6), 3.95 (s, 3H, OCH3), 3.94 (s, 3H, OCH3). 
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3-Bromo-4,5-dimethoxybenzyl alcohol (62) 
OH To a solution of61 (39 g, 0.16 mol) in MeOH (150 mL) and THF 
(150 mL) was added NaB~ (3.0 g, 0.080 mol) in portions over a 
Br period of 3 h. The solution was stirred at room temperature for 11 h, 
followed by removal of the solvent on a rotary evaporator. The yellow 
solid was dissolved with aqueous 10% HCl (100 mL) and transferred to a separatory 
funnel. The aqueous layer was extracted with EtOAc (3 x 50 mL) and the combined 
organic layers were washed with brine (3 x 50 mL), dried over MgS04, filtered, and the 
solvent was evaporated to give a yellow-tinted oil. The product was used in the next step 
without purification (40 g, 99%); 1H NMR: 8 7.05 (d, J=1.8 Hz, 1H, H-2), 6.82 (d, J=1.8 
Hz, 1H, H-6), 4.53 (s, 2H, H-a), 3.82 (s, 3H, OCH3), 3.80 (s, 3H, OCH3), 2.02 (s, 1H, 
OH); MS (m/z): 248 (M++2, 98), 246 (W, 100), 231 (15), 96 (57), 84 (12). 
1-tert-Butyldimethylsilyl-3-bromo-4,5-dimethoxybenzyl ether ( 63) 
To a cooled (0 °C) solution of 62 ( 40 g, 0.16 mol) and 
imidazole (11 g, 0.16 mol) in anhydrous DMF (80 mL) was 
added tert-butyldimethylsilyl chloride (29 g, 0.19 mol). After 
stirring for 48 h at room temperature, the reaction mixture was 
quenched by adding water (50 mL), and extracted with ethyl acetate (3 x 30 mL). The 
combined organic layers were washed with water (50 mL x 3), and brine (20 mL x 2), 
dried over MgS04, filtered, and the solvent was evaporated. The residue was purified by 
flash column chromatography (20% EtOAclhexane) to afford 63 (51 g, 88%) as a yellow 
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oil; 1H NMR: 8 6.98 (d, J=1.9 Hz, lH, H-2), 6.79 (s, J=1.9 Hz, 1H, H-6), 4.57 (s, 2H, H-
a), 3.77 (s, 3H, OCH3), 3.75 (s, 3H, OCH3), 0.87 (s, 9H, C-CH3), 0.19 (s, 6H, Si-CH3); 
MS (mlz): 360 (M+, 5), 362 ~+2, 5). 
1-tert-Butyldimethylsilyl-3-hydroxy-4,5-dimethoxybenzyl ether (64) 
t-Butyllithium (1.6 Min hexane, 23 rnL, 0.040 mol) was 
added dropwise to a solution of 63 (18 g, 0.030 mol) in 
anhydrous THF (300 rnL), under argon at -78 °C. After 
stirring for 0.5 h, to the reaction mixture was then added 
dropwise B(OCH3)3 ( 4.4 mL, 0.040 mol), and the mixture allowed to warm to room 
·temperature overnight. Hydrogen peroxide aqueous solution (37%, 100 mL) was then 
added and the resulting mixture was stirred for 12 h. The reaction was quenched with 
aqueous 1.0 M HC1 (20 mL), and the mixture was concentrated in vacuo to give a 
residue. Water (20 rnL) was added to the residue and the mixture was extracted with ethyl 
acetate (20 mL x 3), washed with water (30 mL x 3), dried over MgS04, filtered, and the 
solvent was evaporated. The residue was purified by flash column chromatography (5% 
EtOAc/hexane) to afford 64 (10 g, 71 %) as a colorless oil; 1H NMR: 8 6.55 (d, J=1.7 Hz, 
1H, H-2), 6.50 (d, J=1.7 Hz, 1H, H-6), 5.90 (s, 1H, OH), 4.64 (s, 2H, H-a), 3.87 (s, 3H, 
OCH3), 3.85 (s, 3H, OCH3), 0.93 (s, 9H, C-CH3), 0.10 (s, 6H, Si-CH3); 13C NMR: 8 
152.4, 149.3, 138.0, 126.5, 105 .6, 101.9, 64.9, 61.2, 55.9, 26.2, 18.6, -5.1 ; MS (mlz): 297 
(M+, 5), 241 (100), 167 (83), 75 (13). 
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1-tert-Butyldimethylsilyl-3-benzyloxy-4,5-dimethoxybenzyl ether (65) 
To a suspension of anhydrous potassium carbonate (25 g, 0.18 
mol) in acetone (300 mL) was added 64 (9.8 g, 0.030 mol) and 
benzyl bomide (7.3 mL, 0.050 mol). After being refluxed for 4 h, 
the reaction mixture was filtered and concentrated in vacuo. 
Water (20 mL) was added and the mixture was extracted with CH2Ch (50 mL x 3). The 
combined organic extracts were washed with water (15 mL x 3), dried over anhydrous 
MgS04, filtered, and the solvent was evaporated. The residue was purified by flash 
column chromatography (5% EtOAc/hexane) to afford 65 (11 g, 85%) as a colorless oil; 
1HNMR: 8 7.29-7.45 (m, 5H, Ar-H), 6.59 (b, 1H, H-2), 6.57 (b, 1H, H-6), 5.14 (s, 2H, 
H-u'), 4.64 (s, 2H, H-u), 3.87 (s, 3H, OCH3), 3.85 (s, 3H, OCH3), 0.93 (s, 9H, C-CH3), 
0.07 (s, 6H, Si-CH3); 13C NMR: 8 153.5, 152.5, 137.5, 137.4, 137.3, 128.7, 127.9, 127.3, 
105.1, 103.3, 71.1, 65.0, 61.1, 56.2, 26.1 , 18.6, -5 .1; MS (m/z) : 388 (~+1, 25), 330 (34), 
257 (100), 91 (99), 73 (30). 
3-Benzyloxy-4,5-dimethoxybenzyl alcohol (66) 
To a cooled (0 °C) solution of 65 (3.5 g, 9.0 mmol) in THF (1 00 
mL) was added tetrabutylammonium fluoride (21 mL, 18 mmol, 
1.0 M in THF). After stirring for 2 h at 0 °C, the reaction was 
quenched by addition of water (30 mL), and then the mixture was 
extracted with ethyl acetate (25 mL x 3). The combined organic layers were washed with 
water (15 mL x 3), brine (10 mL x 2), dried over anhydrous MgS04, filtered, and the 
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solvent was evaporated. The residue was purified by flash column chromatography (10% 
EtOAc/hexane) to afford 66 (2.5 g, 99%) as a colorless oil; 1H NMR (500 MHz): ~ 7.26-
7.40 (m, 5H, Ar-H), 6.62 (s, 1H, H-2), 6.59 (s, 1H, H-6), 5.11 (s, 2H, H-a), 4.56 (s, 2H, 
H-a), 3.86 (s, 3H, OCH3), 3.84 (s, 3H, OCH3), 2.03 (s, 1H, OH); 13C NMR: ~ 153.7, 
152.6, 138.2, 137.3, 136.8, 128.7, 128.0, 127.4, 106.1, 104.4, 71.2, 65.5, 61.1, 56.3; MS 
(m/z): 274 (M+, 1), 142 (100), 91(56). 
3-Benzyloxy-4,5-dimethoxybenzyl chloride (67) 
To a solution of 66 (2.2 g, 7.9 mmol) in anhydrous benzene (50 
mL) was added dropwise thionyl chloride (1.1 mL, 11 mmol). 
After stirring at room temperature overnight, the reaction was 
quenched by addition of water (20 mL), and the mixture was 
extracted with ethyl acetate (15 mL x 3). The combined extracts were washed with 
aqueous saturated NaHC03 (10 mL x 3), water (20 mL x 2), dried over anhydrous 
MgS04, filtered, and the solvent was evaporated. The residue was purified by flash 
column chromatography (10% EtOAc/hexane) to afford a colorless oil67 (2.4 g, 98%) 
which was directly used in the following step; 1H NMR: ~ 7.32-7.47 (m, 5H, Ar-H), 6.66 
(d, 1=1.9 Hz, 1H, H-2), 6.62 (d, 1=1.9 Hz, 1H, H-6), 5.13 (s, 2H, H-a), 4.51 (s, 2H, H-
a), 3.88 (s, 3H, OCH3), 3.87 (s, 3H, OCH3); MS (m/z): 292 (W, 13), 91 (100). 
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3-Benzyloxy-4,5-dimethoxyphenylacetonitrile (68) 
a' 
To the solution of 67 (2.2 g, 7.1 mmol) in DMSO (1.3 mL) and 
benzene (0.65 mL) was added NaCN powder (0.92 g, 18 mmol) 
in 3 portions. After stirring for 2 hat room temperature, the 
reaction mixture was poured into water (10 mL) and extracted 
with benzene (10 mL x 3). The combined organic layers were washed with brine (10 mL 
x 3), dried over anhydrous MgS04, filtered, and the solvent was evaporated. The residue 
was purified by flash column chromatography (10% EtOAc/hexane) to afford 68 (1.8 g, 
91 %) as a colorless oil; 1H NMR (500 MHz): 8 7.31-7.45 (m, SH, Ar-H), 6.57 (s, 1H, H-
2), 6.53 (s, 1H, H-6), 5.13 (s, 2H, H-a), 3.87 (s, 3H, OCH3), 3.86 (s, 3H, OCH3), 3.66 (s, 
2H, H-a); 13C NMR: 8 154.0, 153.2, 138.9, 136.9, 128.8, 128.3, 127.5, 125.4, 118.0, 
107.6, 105.7, 71.5, 61.2, 56.5, 24.0; MS (m/z): 283 (~+1, 10), 177 (24), 91 (100). 
3-Benzyloxy-4, 5-dimethoxybenzoic acid (69) 
A solution of 68 (1.4 g, 4.9 mmol) in ethanol (25 mL) and 
0 a 
aqueous 4.0 M NaOH (2.0 mL) was heated at reflux for 20 h. 
OCH3 The reaction mixture was then cooled to room temperature and 
diluted with water (10 mL) and then washed with CH2Ch (15 
mL x 3). The aqueous layer was separated, acidified with aqueous concentrated HCl to 
pH = 1 and re-extracted with CH2Ch (5 mL x 3). The combined organic extracts were 
washed with brine (15 mL x 2), dried over anhydrous MgS04, filtered, and the solvent 
was evaporated to give 69 (1.4 g, 90%) as a white solid, which was used directly in the 
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next step; 1H NMR (500 :rvffiz): 8 7.28-7.44 (m, 5H, Ar-H), 6.56 (d, 1H, 1=1.5 Hz, H-2), 
6.51 (d, 1H, 1=1.5 Hz, H-6), 5.11 (s, 2H, H-a'), 3.85 (s, 3H, OCH3), 3.84 (s, 3H, OCH3), 
3.54 (s, 2H, H-a); 13C NMR: 8 177.6, 153.7, 152.7, 138.3, 137.2, 128.8, 128.7, 128.1, 
127.6, 108.9, 107.1, 71.4, 61.1, 56.4, 41.4; MS (m/z): 301 ~' 6), 196 (16), 151 (32), 91 
(22), 84 (100), 47 (24). 
N -( (R)-a-Methylbenzyl)-(3-benzyloxy-4,5-dimethoxy )phenylacetamide (70) 
a 
0 To a stirred solution of oxalyl chloride (0.11 mL, 1.3 mmol) 
in anhydrous benzene (10 mL) were added 69 (250 mg, 0.84 
mmol) in one batch and DMF (2 drops). The reaction 
mixture was stirred until the evolution of gas ceased. The 
benzene was evaporated using a rotary evaporator to give 
crude acid chloride 69a, which was used directly in the next step. 
The crude acid chloride 69a was re-dissolved in CH2Ch (2.0 mL) at 0 °C and the 
resulting solution was dropwise added to a stirred mixture of (R)-a-methylbenzylamine 
(0.17 mL, 1.0 mmol) and CH2Ch/aqueous 5% NaOH (1:1.5, 5 mL). After stirring at room 
temperature for 1 h, the reaction mixture was extracted with chloroform (10 mL x 3), 
washed with water (15 mL x 2), dried over anhydrous MgS04 , filtered, and the solvent 
was evaporated. The residue was purified by flash column chromatography (50% 
EtOAc/hexane) to afford amide 70 (280 mg, 84%) as a viscous oil; 1H NMR (500 :rvffiz): 
8 7.42-7.17 (m, 10H, Ar-H), 6.48 (d, 1=0.6 Hz, 1H, H-2), 6.44 (d, 1=0.6 Hz, 1H, H-6), 
5.62 (d, 1=8.3 Hz, 1H, N-H), 5.11 (q, 1=8.3 Hz, lH, H-a"), 5.08 (s, 2H, H-a'), 3.87 (s, 
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3H, OCH3), 3.82 (s, 3H, OCH3), 3.47 (s, 2H, H-a), 1.38 (d, 1=8.3 Hz, 3H, ~-CH3); 13C 
NMR: cS 170.0, 153.9, 152.9, 143.4, 138.2, 137.1, 130.5, 128.8, 128.7, 128.1, 127.6, 
127.4, 126.2, 108.8, 106.9, 71.3, 61.1, 56.4, 48.9, 44.3, 21.9; MS (m/z): 404 ~. 36), 300 
(7), 257 (10), 151 (17), 105 (99), 91 (100). 
Methyl 4-hydroxyphenylacetate (72) 
0 
To methanol (50 mL), which was pre-cooled to -10 °C, was added 
dropwise thionyl chloride (4.4 mL, 0.060 mol). 4-Hydroxyphenyl-
acetic acid 71 (6.1 g, 0.040 mol) was then added in one batch. The 
cooling bath was removed, and the mixture was refluxed for 3 h. The 
reaction was quenched by addition of water (30 mL), and then the mixture was extracted 
with ethyl acetate (20 mL x 3). The combined organic phases were washed with water 
(20 mL x 3), dried over MgS04 , filtered, and the solvent was evaporated to give 72 (5.9 
g, 90%) as a colorless oil; 1H NMR: cS 7.16 (d, 1=8.0 Hz, 2H, H-2, H-6), 6.78 (d, 1=8.0 
Hz, 2H, H-3, H-5), 5.52 (s, 1H, OH, D20 exchangeable), 3.70 (s, 3H, COOCH3), 3.56 (s, 
2H, H-a). 
Methyl 4-( trifluoromethanesulfonato )phenylacetate (73) 
0 
To a solution of methyl 4-hydroxyphenylacetate 72 (5.8 g, 0.035 
mol) and 2,6-lutidine (16 mL, 0.14 mol) in CH2Ch (100 mL), 
which was pre-cooled to -40 °C (dry ice in acetone), was added 
dropwise trifloromethanesulfonic anhydride (Tf20, 12 mL, 0.070 
mol). After stirring for 2 h, the reaction was added water (40 mL) and the mixture was 
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extracted with EtOAc (30 mL x 3). The combined organic phases were dried over 
MgS04 , filtered, and the solvent was evaporated. The residue was purified by flash 
column chromatography (5% EtOAclhexane) to afford compound 73 (8.7 g, 83%) as a 
colorless oil; 1H NMR: () 7.49 (d, 1=8.0 Hz, 2H, H-2, H-6), 7.35 (d, 1=8.0 Hz, 2H, H-3, 
H-5), 3.81 (s, 3H, COOCH3), 3.76 (s, 2H, H-a). 
Methyl 4-( 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenylacetate (75) 
A flask maintained under argon was charged with [1,1 '-bis-
( diphenylphosphino )ferrocene ]dichloropalladium(ll) (270 mg, 
0.34 mmol), Et3N (4.2 mL) and bis(pinacolato)diboron (28 
mg, 110 mmol) in dioxane (50 mL). Compound 73 (3.0 g, 100 
mmol) was added to the mixture. After stirring at 80 °C for 5 h, the reaction was diluted 
with benzene (50 mL) and the mixture was transferred to a separatory funnel. The 
aqueous layer was extracted with benzene (20 mL x 2) and the combined organic layers 
were washed with brine (20 mL x 3), dried over MgS04, filtered, and the solvent was 
evaporated. The residue was purified by flash column chromatography (10% 
EtOAc/hexane) to afford 75 (2.1 g, 75%) as a colorless oil; 1H NMR (500 MHz): () 7.78 
(d, 1=7.8 Hz, 2H, H-2, H-6), 7.29 (d, 1=7.8 Hz, 2H, H-3, H-5), 3.67 (s, 3H, COOCH3), 
3.63 (s, 2H, H-a), 1.33 (s, 12H, CH3); 13C NMR: () 171.8, 137.2, 135.2, 128.8, 83.9, 68.0, 
52.2, 41.5, 24.9; MS (m/z): 276 (M++1, 6), 261 (7), 190 (11), 177 (16), 91 (49), 84 (100). 
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1-(R)-[ 4-( 4,4,S,S-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl]-N -( (R)-a-
methylbenzyl)-6,7-dimethoxy-8-benzyloxy-1,2,3,4-tetrahydroisoquinoline (77a) and 
1-(R)-( 4-( 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)-N -( (R)-a-
methylbenzyl)-6-benzyloxy-7 ,8-dimethoxy-1,2,3,4-tetrahydroisoquinoline (77b) 
4 
3 OCH3 4 
13" 3 2 13" 2 H,o I OCH3 
"'0 ¥~~ OCH3 
77a &~ l~~ 77b \" 
Compound 57 (190 mg, 0.31 mmol), POCh (1.0 mL) and benzene (3.0 mL) were 
combined under an atmosphere of argon and bought to a gentle reflux. After 
approximately 8 h, the solvent was evaporated on a rotary evaporator and the residual 
POCh was evaporated on a vacuum pump for 1 h. The resultant residue was re-dissolved 
in MeOH (5.0 mL), and the solution was cooled to -78 °C in a dry ice bath. To this 
solution was added NaB~ (58 mg, 1.5 mmol) in five portions over a period of 5 h. The 
reaction was quenched through the addition of aqueous 10% HCl (10 mL), and the 
mixture was stirred at room temperature for 10 min. The MeOH was evaporated on a 
rotary evaportator, and the residue was re-dissolved in CH2Ch (15 mL) and transferred to 
a separatory funnel containing H20 (5.0 mL). The combined aqueous layers were further 
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extracted with CH2Ch (3 x 10 mL). The combined organic layers were washed with brine 
(3 x 5.0 mL), dried over MgS04, filtered, and the solvent was evaporated. The residue 
was purified by flash column chromatography (5% MeOH/CH2Ch) to give a mixture of 
regioisomers 77a and 77b (170 mg, 88%) as a colorless oil. Column chromatography or 
preparative TLC failed to separate this pair of regioisomers. Therefore, 1H NMR spectra 
of 77a/77b could not be obtained separately. However, because it is a pair of 
regioisomers, 77a and 77b have the same molecular mass. APCI-MS (mlz) (77a/b): 
620.25 ~ +2, 100). 
1-(R)-4-( 4,4, 5, 5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)-N-[(R)-a-
methylbenzyl]- 6,7-dimethoxy-8-benzyloxy-2,3,4-tetrahydroisoquinoline (77a) 
To a solution of compound 85a (300 mg, 0.49 mmol) in 
10 mL of DMSO, bis(pinacolato)diboron (140 mg, 0.55 
mmol), KOAc (152 mg, 1.5 mmol) and PdCh(dppf) (30 
mg, 0.015 mmol) were added under argon. The reaction 
mixture was stirred at 80 °C for 6 h followed by the 
addition of water (10 mL). The aqueous layers were 
extracted with EtOAc (10 mL x 3). The combined organic layers were washed with water 
(5.0 mL x 3), brine (5.0 mL x 2), dried over MgS04, filtered, and the solvent was 
evaporated. The residue was purified by preparative chromatography (5% EtOAc/hexane 
with 0.4% Et3N) to give 77a (210 mg, 68%) as a colorless powder; 1H NMR (500 MHz): 
8 7.60-6.63 (m, 14H, Ar-H), 6.50 (s, 1H, H-5), 5.13 (d, 1=9.7 Hz, 1H, H-a), 4.23 (d, 
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1=9.7 Hz, 1H, H-a), 3.89 (m, 7H, OCH3, H-3), 3.57 (m, 2H, H-a", H-3), 3.36 (m, 1H, H-
4), 2.95 (m, 1H, H-4), 2.77 (m, 2H, H-a), 2.44 (d, 1=4.6 Hz, 1H, H-1), 1.39 (d, 1=1.7 Hz, 
12H, BO(CH3)4), 1.23 (m, 3H, H-~"); 13C NMR: 8 151.9, 150.6, 146.3, 144.3, 140.7, 
137.3, 134.2, 130.9, 130.8, 129.7, 129.3, 128.5, 128.4, 128.3, 127.5, 126.5, 124.6, 107.9, 
83.7, 75.6, 61.1, 58.9, 56.7, 56.1, 41.3, 38.4, 25.1, 25.0, 22.9, 22.4; APCI-MS (m/z): 
620.30 ~+1, 100), 619.30 ~. 25). 
1-(R)-( 4-( 4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)-N -[ (R)-a-
methylbenzyl]-6-benzyloxy-7 ,8-dimethoxy-1,2,3,4-tetrahydroisoquinoline (77b) 
Via a similar procedure as was used with 85a to 
afford 77a, compound 77b (22 mg, 63%) was 
obtained from 85b (35 mg, 0.057 mmol); 1H NMR 
(500 MHz): 8 7.68-6.67 (m, 14H, Ar-H), 6.51 (s, 
1H, H-5), 5.09 (t, 1 AB=5.4 Hz, 2H, H-a), 3. 87 (s, 
3H, OCH3), 3.82 (m, 1H, H-3), 3.66 (s, 3H, 
OCH3), 3.55 (q, 1=6.4 Hz, 1H, H-a"), 3.44 (m, 
1H, H-3), 3.28 (m, 1H, H-4), 2.85 (m, 3H, H-4, H-a), 2.36 (d, 1=4.5 Hz, 1H, H-1), 1.38 
(s, 12H, BO(CH3)3),1.22 (d, 1=7.0 Hz, 3H, H-W'); APCI-MS (mlz): 620.35 (~+1, 100), 
619.35 (~, 27). 
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1-(R)-( 4-Dihydroxyborylbenzyl)-N -[ (R)-a-methylbenzyl]-6, 7 -dimethoxy-8-
benzyloxy-1,2,3,4-tetrahydroisoquinoline (78a) and 
1-(R)-( 4-Dihydroxyborylbenzyl)-N -[ (R)-a-methylbenzyl]-6-benzyloxy-7 ,8-dimethoxy 
-1,2,3,4-tetrahydroisoquinoline (78b) 
4 
OCH3 
.. p 
3 4 0 
13" 3 2 13" 
"'2) I OCH3 "'6 OCH3 
B(OHn B(OHn 
78a 78b 
Aqueous 2.0 M HCl (9.4 mL) and phenylboronic acid (19 mg, 0.16 mmol) were added to 
a mixture of 77a and 77b (51 mg, 0.082 mmol) in THF (6.0 mL) and MeOH (2.0 mL). 
After stirring for 16 hat room temperature, the reaction was quenched with the addition 
of water (5.0 mL). The solvent was removed by a rotary evaporator and the resultant 
mixture was extracted with EtOAc (15 mL). The aqueous layer was re-extracted with 
EtOAc (5.0 x 3 mL) and the combined organic layers were washed sequentially with 
aqueous saturated NaHC03 (5.0 mL), brine (5.0 mL) and dried over MgS04. After 
filtration and removal of solvent in vacuo, the residue was purified by flash column 
chromatography (50% EtOAc/hexane) to give a pair of regioisomers 78a and 78b (31 
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mg, 70%) as a colorless oil. Column chromatography or preparative TLC failed to 
separate this mixture. APCI-MS (mlz) (78alb): 538.20 ~+2, 100). 
1-(R)-( 4-Dihydroxyborylbenzyl)-6, 7 -dimethoxy-8-hydroxy-1,2,3,4-tetrahydro-
isoquinoline (79a) and 
1-(R)-( 4-Dihydroxyborylbenzyl)-7 ,8-dimethoxy-6-hydroxy-1,2,3,4-tetrahydro-
isoquinoline (79b) 
B(OHh B(OHh 
79a 79b 
To a mixture of 78a and 78b (20 mg, 0.037 mmol) in EtOAc (1.0 mL) and EtOH (3.0 
mL) was added aqueous 10% HCl (0.20 mL). The resulting mixture was hydrogenolyzed 
using 10% Pd/C (20 mg) catalyst for 15 h, with stirring. Filtration over Celite followed 
by evaporation of the solvent afforded a residue. The residue was added water (5.0 mL) 
and CH2Ch (5.0 mL), and the mixture was basified to pH= 8 with aqueous saturated 
NaHC03 and transferred to a separatory funnel. The aqueous layer was re-extracted with 
CHzCh (5.0 mL x 3). The combined organic layers were washed with brine (5.0 mL), 
dried over MgS04, filtered, and the solvent was evaporated in vacuo. This residue, as a 
mixture of 79a and 79b, was used directly in the next step without purification.1H NMR 
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spectrum showed a mixture of this pair of regioisomers, however, 1H NMR spectra of 
79alb could not be obtained separately due to separation difficulties. APCI-MS (mlz) 
(79alb): 344.10 (M++2, 19). 
N -[ (R)-a-Methylbenzyl]-N-[ (3-benzyloxy-4,5-dimethoxy )phenethyl]-4-iodophenyl 
acetamide (81) 
~ 6 
a I ~ OCH3 
· I 4 
To a solution of oxalyl chloride (0.25 mL, 1.4 mmol) in 
dry benzene (20 mL) were added 82 (0.60 g, 2.3 mmol) 
2 3 OCH3 
:1 ;~~ and DMF (2 drops). The mixture was stirred until the evolution of gas ceased. The benzene was removed by 
rotary evaporation to give an acid chloride. 
The acid chloride was re-dissolved in CH2Ch (10 mL) at 0 °C. To this solution, a mixture 
of 58 (660 mg, 1.7 mmol) and CH2Clz-aqueous 5% NaOH (1:1.5, 10 mL) was added. 
After stirring at room temperature for 1 h, the mixture was extracted with chloroform (5.0 
mL x 3). The combined extracts were washed with water (15 mL), dried over MgS04, 
filtered, and the solvent was evaporated in vacuo. The residue was purified by flash 
column chromatography (30% EtOAclhexane) to afford 81 (1.1 g, 98%) as a viscous oil; 
1H NMR (500 MHz, toluene-d8, 373 K, mixture of rotamers): () 7.44-6.20 (m, 16H, Ar-
H), 5.34 (bs, 1H, H-a."), 4.89 (s, 2H, H-a.), 3.75 (s, 3H, OCH3), 3.53 (s, 3H, OCH3), 3.43 
(s, 2H, H-a."), 3.20 (m, 2H, H-a., H-~), 2.58 (bs, 1H, H-a.), 2.31 (bs, 1H, H-~), 1.25 (d, 
1=6.9 Hz, 3H, H-~"); MS (mlz): 636 (W +2, 10), 271 (27), 270 (92), 217 (13), 105 (100), 
91 (81). 
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4-Iodophenylacetic acid (82) 
A mixture of 84 (3.4 g, 14 mmol) in ethanol (100 mL) and 4.0 M 
0 a 
rQ I NaOH (20 mL) was heated at reflux for 20 h. The reaction mixture was then cooled to room temperature and diluted with additon of 
water (30 mL). The mixture was extracted with CH2C}z (15 mL x 3). The aqueous layer 
was acidified with aqueous concentrated HCl to pH= 1 andre-extracted with CH2Ch (10 
mL x 3). The combined organic layers were washed with brine (2 x 10 mL), dried over 
anhydrous MgS04 , filtered, and the solvent was evaporated in vacuo to give 82 (3.1 g, 
84%) as a white solid; 1H NMR (500 MHz): 8 11.01 (bs, 1H, COOH), 7.67 (d, 1=8.2 Hz, 
2H, H-2, H-6), 7.03 (d, 1=8.2 Hz, 2H, H-3, H-5), 3.59 (s, 2H, H-a); 13C NMR: 8 176.9, 
137.9, 132.9, 131.6, 93.2, 40.6; MS (m/z): 261 {W, 93), 217 (100), 91 (21). 
4-Iodophenylacetonitrile (84) 
P.
3 
1 
4 
5 
6 
CN 
To a solution of 4-iodobenzyl chloride (83) ( 4.3 g, 17 mmol) in DMSO 
(20 mL) and benzene (30 mL) was added NaCN powder (2.1 g, 42 mmol) 
in 3 portions. After stirring for 2 h at room temperature, the reaction was 
poured into water (15 mL) and the mixture was extracted with benzene 
(10 mL x 3). The combined organic layers were washed with brine (2 x 10 mL), dried 
over anhydrous MgS04, filtered, and the solvent was evaporated in vacuo to give a 
residue that was purified by flash column chromatography (10% EtOAc/hexane) to afford 
84 (3.5 g, 85%) as a white powder; 1H NMR (500 MHz): 8 7.72 (d, 1=8.3 Hz, 2H, H-2, 
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H-6), 7.08 (d, 1=8.3 Hz, 2H, H-3, H-5), 3.69 (s, 2H, H-a); 13C NMR: 8 138.5, 129.9, 
129.8, 117.4, 93.8, 23.5; MS (m/z): 243 (W+1, 100), 116 (88), 89 (42). 
1-(R)-(4-Iodobenzyl)-N-[(R)-a.-methylbenzyl]-8-benzyloxy-6,7-dimethoxy-1,2,3,4-
tetrahydroisoquinoline (85a) and 
1-(R)-(4-Iodobenzyl)-N-[(R)-a.-methylbenzyl]-6-benzyloxy-7,8-dimethoxy-1,2,3,4-
tetrahydroisoquinoline (85b) 
Compound 81 (0.99 g, 1.6 mmol), POCh (6.0 rnL) and benzene (17 rnL) were combined 
under an atmosphere of argon and bought to a gentle reflux. After approximately 5 h, the 
4 
, .. p 
~6 0 
85a 85b 
solvent and excess POCh were evaporated on a rotary evaporator and finally on a 
vacuum pump for 1 h. The resultant residue was re-dissolved in MeOH (7.0 rnL) and the 
solution was cooled to -78 °C in a dry ice bath. To this solution was added NaB~ (0.30 
g, 7.9 mmol) in five portions over 3 h. The reaction was quenched through the addition of 
aqueous 10% HCl (10 rnL), and the mixture was stirred at room temperature for 30 min. 
The MeOH was evaporated on a rotary evaporator. The residue was re-dissolved in 
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CHzCh (15 mL) and transferred to a separatory funnel containing H20 (5.0 mL). The 
combined aqueous layers were re-extracted with CH2Cl2 (3 x 5.0 mL). The combined 
organic layers were washed with brine (2 x 5.0 mL), dried over MgS04, filtered, and the 
solvent was evaporated in vacuo. The residue was purified by flash column 
chromatography (30% EtOAc/hexane) to give compounds 85a (370 mg, 37%) as a 
colorless oil and 85b (400 mg, 40%) also as a colorless oil; 85a: 1H NMR (500 MHz): o 
7.39-6.47 (m, ISH, Ar-H), 5.20 (d, 1=9.7 Hz, IH, H-a'), 4.20 (d, 1=9.7 Hz, IH, H-a'), 
3.91 (s, 3H, OCH3), 3.89 (s, 3H, OCH3), 3.73 (m, IH, H-3), 3.60 (q, 1=7.3 Hz, IH, H-
a"), 3.50 (m, IH, H-3), 3.39 (d, 1=6.0 Hz, IH, H-4), 2.96 (m, IH, H-4), 2.65 (d, 1=4.5 
Hz, 2H, H-a), 2.43 (d, 1=4.5 Hz, IH, H-1), 1.25 (d, 1=7.3 Hz, 3H, H-J3"); 13C NMR: o 
152.1, 150.6, 146.4, 140.8, 137.3, 136.6, 132.4, 130.8, 129.5, 128.6, 128.5, 128.3, 127.4, 
126.6, 124.2, 107.8, 90.6, 75.7, 61.2, 58.9, 57.2, 56.2, 40.7, 38.5, 31.1, 23.0, 22.4; APCI-
MS (m/z): 620.05 (M++l, 100); 
85b: 1H NMR (500 MHz): o 7.53-6.66 (m, 14H, Ar-H), 6.51 (s, 1H, H-5), 5.10 (t, 
1As=5.4 Hz, 2H, H-a'), 3.87 (s, 3H, OCH3), 3.68 (m, 4H, H-3, OCH3» 3.53 (q, 1=6.4 Hz, 
IH, H-a"), 3.45 (m, IH, H-3), 3.33 (m, 1H, H-4), 2.87 (m, IH, H-4), 2.69 (m, 2H, H-a), 
2.36 (d, 1=3.7 Hz, IH, H-1), 1.23 (d, 1=4.3 Hz, 3H, H-J3"); 
APCI-MS (m/z): 620.15 (W+l, 100). 
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3.1 Introduction 
Chapter 3 
Syntheses of lsoquinolones 
The work presented in this section deals with a route to the syntheses of 
thalifoline (19), N-methylcorydaldine (21), corydaldine (22) and some other tetrahydro-
isoquinolone analogues. As described in Chapter 1, an efficient synthetic route towards 
thalifoline was accomplished by Wang and Georghiou.48 In addition, a different approach 
involving oxidation of N-methyltetrahydroisoquinolines to afford the corresponding 
amide tetrahydroisoquinilones using iodosylbenzene (ISB) was recently reported by 
Huang et al. 51 in 2002. Schultz reported on the use ofRu02-Nai04 as an oxidant47 
describing its advantages, such as ease of handling with other reagents, and the use of 
mild reaction conditions. In this section, the research described is focused on the use of 
similar oxidation methodology to those of Huang, but using Ru02-Nal04 as oxidation 
reagent. 
3.2 Results and Discussion 
3.2.1 Attempts towards the Synthesis of N-Methylcorydaldine (21) 
Retrosynthetic analysis of target tetrahydroisoquinolones 19, 21 and 22 suggested 
approaches for their syntheses. From the efforts towards the synthesis of (-)-cycleanine 
(8) described in the previous chapters, it is clearly evident that the tetrahydroisoqinoline 
rings could be easily formed from the corresponding amides via the Bischler-Napieralski 
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cyclization reaction. It was postulated that after the formation of the isoquinoline rings, 
oxidation using Ru02-Nal04 as a reagent would result in the desired isoquinolones. 
As shown in Scheme 20, the synthesis started from vanillin (23). Methylation (or 
benzylation) of the phenolic group of vanillin (23) afforded the methylated vanillin 92 (or 
the benzyl ether 92a), which were both reduced, usually with quantitative yield, to the 
corresponding alcohols 93 (and 93a) using NaB~. Chlorination, cyanation, and then 
hydrolysis of the resulting primary nitriles 95 (and 95a) completed the formation of the 
respective carboxylic acids 96 (and 96a). Although it took five steps to produce the two 
target intermediates 96 and 96a, all of these steps gave very high yields. It should be 
mentioned that these two compounds were used as starting materials in the work 
vanillin (23) 
96 Rt =CH3 
96a R2 = Bn 
92 R1=CH3 
92a R2 = Bn 
95 Rt =CH3 
95a R2 = Bn 
93 Rt =CH3 
93a R2 = Bn 
+c 
CI~OCH3 
~OR 
94 R1 =CH3 
94a R2 = Bn 
Conditions: a) 92: Me2S04, NaOH, H20, CH2CI2, Adogen 464®; 92a: BnBr, K2C03, reflux in acetone; 
b) NaBH4, MeOH, THF; c) SOC12, benzene; d) NaCN, DMSO, benzene; e) aq. 4.0 M NaOH, ethanol, reflux. 
Scheme 20. 
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described in this thesis because they were commonly used and shared in the Georghiou 
laboratory. 
96 
I ..-9 N .. e H3COJCQ 
H3CO 'CH3 
0 
N-methylcorydaldine (21) 
Condition: (a) (COCI)z, benzene, DMF, then methylamine, aq. 5% NaOH-CH2Cl2, 77%; (b) 
BH3ffHF, BF3/Et20, then aq. 20% HCl, 84%; (c) Ac20/HCOOH, 80%; (d) POC13, reflux in 
benzene; NaBH4, MeOH, 88%; (e) PCC, CH2Cl2, very low yield. 
Scheme 21. 
The synthesis of N-methylcorydaldine (21) is outlined in Scheme 21. Acid 96 
reacted with oxalyl chloride to afford the acid chloride, which then reacted in situ with 
methylamine to furnish the amide 97 under the usual Schotten-Baumann conditions. In 
the presence of borane and boron trifluoride, the amide 97 was reduced to the amine 98 
(84% ), which could be acylated to afford the desired amide 99 (80% ). Bischler-
Napieralski cyclization of 99 afforded 100 in good yield (88% ). As a key intermediate in 
this synthesis, the N-methylisoquinoline 100 was completed in four steps in an overall 
yield of 46%. 
It was at this stage that different oxidation methodologies could be investigated 
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for the formation of the tetrahydroisoquinolone 21. For this particular synthetic target, the 
research presented here will concentrate on the C-1 regioselective oxidation of the 
tetrahydroisoquinolines using Ru02-Nai04 and other oxidation reagents, such as 
pyridinium chlorochromate (PCC) and the Dess-Martin periodinane.68 
The selective oxidation of isoquinoline 100, posed significant difficulty. The use 
of Ru02-Nal04 reagents was disappointing. This oxidation procedure resulted in a 
mixture, which could not be separated. Oxidation of C-1 of isoquinoline 100 requires a 
regioselective oxidant since there is another methylene group and a methyl group 
adjacent to the nitrogen atom. Ru02-Nal04 is a very strong oxidizing reagent, which 
might oxidize these other positions that are adjacent to the nitrogen atom and benzylic 
position, in addition to the desired C-1, resulting a mixture of oxidation products. The use 
of the alternative reagents, PCC and the Dess-Martin reagent, was also evaluated. 
Although no target compound was obtained from the Dess-Martin periodinane oxidation 
reaction, the PCC oxidation of the isoquinoline 100 afforded a very small amount of the 
target molecule N-methylcorydaldine (21). The structures of other two unknown products 
were hard to be determined. The PCC oxidation result verified the previous speculation, 
but unfortunately, the yield from this reaction was very low. 
The experimental results showed that the success of the final oxidation step is 
related to the selection of the appropriate reagent. Although a positive result was obtained 
from the oxidation reaction with PCC, none of the oxidation reagents that were tried gave 
satisfactory results. Attention was therefore directed towards modification of the 
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precursor. 
3.2.2 Attempts towards the Syntheses of Thalifoline (19) and Corydaldine (22) 
~~a>2Et~~ 
VV·'11cH2oms 
101 
0)0 NH 
., 1/cH201BS 
102 
Conditions: a) Ru02 (cat.), Nal04, CH3CN; b) NaOMe, MeOH; 75% for two steps. 
Scheme 22. 
• e 
103 
Condition: (a) (COClh, benzene, DMF, then benzylamine, aq. 5% NaOH-CH2CI2, 77%; (b) BH3/THF, 
BF3/Et20, then aq. 20% HCI, 84%; (c) Ac20/HCOOH, 80%; (d) POCI3, reflux in benzene; NaBH4, 
MeOH, 88%; (e) H2, Pd/C, ethanol, rt, 12h, 89%. 
Scheme 23. 
As reported by Schultz,47 a carbamate 101 could be easily selectively oxidized to 
its corresponding compound 102 in high yield (75% for two steps) using Ru02-Nai04 
system (Scheme 22). Based on this, attention was turned to the modification of the 
precursor to the oxidation step. A carbamate was chosen as the oxidation precursor. The 
modified synthetic route is shown in Schemes 23-25. Synthesis of the isoquinoline 103 
was achieved in good yields. Carboxylic acid 96a was chosen as the starting material. 
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The synthesis of 96a, another compound shared in the Georghiou laboratory and easily 
synthesized from vanillin (23), was shown previously in Scheme 20. 
Carboxylic acid 96a, after conversion to the corresponding acid chloride, afforded 
the amide 97a using typical Schotten-Baumann conditions with benzylamine (77%). The 
amide 97a was reduced to the amine 98a using BHJITHF and BF3/Et20 (84%). Acylation 
of amine 98a in HC02H/ Ac20 formed amide 99a (80% ), which afforded the cyclic 
benzyl amine 100a (88%) via BNC reaction, followed by the reduction using NaB}4. 
Palladium-catalyzed hydrogenolysis of 100a removed the two benzyl groups to afford the 
key compound 103 in high yield (89% ). The direct oxidation of the intermediate 103 
however, also did not give a satisfactory result (Scheme 24). As a result, further 
exploration of the syntheses of corydadine (22) and thalifoline (19) from 104 was 
I *- I · ---~ Corydaldine (22) or Thalifoline (19) H3CO:co H3CO~ 
HO .Q N...._H HO .Q N...._H 
0 
103 104 
Condition: a) Ru0rNai04, CH3CN-CCl4-H20. 
Scheme 24. 
abandoned. 
Based on the report of Schultz,47 attention was next turned towards the conversion 
of the tertiary amine 103 to the corresponding carbamate. As shown in Scheme 25, the 
phenolic group of 103 also became derivatized and resulted in a carbamate-carbonate 
analogue 105. Oxidation of 105 with Ru02-Nai04 gave a very clean reaction, which 
afforded isoquinolone 106 in acceptable yield (68%). Due to time constraints, our 
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Conditions: (a) CICOOEt, aq. NaHC03, 85%; (b) Ru02-Nal04, CH3CN-CCkH20, 68%. 
Scheme 25. 
research in this area ceased at this stage, but it is apparent that thalifoline (19) and 
corydaldine (22) could be easily prepared from compound 106. 
3.3 Summary 
Although the goals of synthesizing thalifoline (19) and corydaldine (22) were not 
achieved, N-methylcorydaldine (21) was synthesized, albeit in very low yield. Oxidation 
of the carbamate-carbonate 105 afforded the corresponding isoquinolone 106 in 
acceptable yield using Ru02-Nal04. The difficulties that have been identified in these 
synthetic trials are related to the selection of the oxidation reagents and the nature of the 
precursor to the oxidation step. Such information will lead to the modification of future 
synthetic proposals and will be important for future endeavors. 
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3.4 Experimental 
General 
Flash column chromatography was performed using 240-400 mesh silica} gel and 
preparative layer (1 mm) chromatography (PLC) was conducted using 60 mesh silica gel. 
All solvents and reagents used were either of the highest commercial grade available 
from Sigma-Aldrich and/or were redistilled (CH2Ch, hexane, and benzene distilled over 
CaH2, CHCh distilled over P40 10) . 1H and 13C NMR spectra were obtained on a General 
Electric GE-300 NB spectrometer at 300 MHz in CDCh unless otherwise specified and 
shifts are relative to an internal trimethylsilane signal. Some of the NMR data were 
obtained on the Bruker Advance 500 MHz instrument with a TXI inverse-detect gradient 
probe, and these data are designated in the experimental section. The following 
abbreviations are used in the description in the 1H NMR: s (singlet), d (doublet), t 
(triplet), q (quartet), m (multiplet) and b (broad). The 13C NMR spectra shifts were 
measured relative to the solvent. Overlap may have prevented the reporting of all 
resonances when the spectral data of compounds were obtained from mixtures. NMR free 
induction decay data were processed using WinNuts (Acorn NMR software). Low 
resolution mass spectral data were obtained from the V.G. Micromass 7070HS 
instrument. 
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N-Methyl-3, 4-dimethoxyphenylacetamide (97) 
To a stirred solution of oxalyl chloride (1.1 mL, 5.8 mmol) in 
ex H3COXYXO 
I anhydrous benzene (50 mL) were added compound 96 (2.0 g, # N 
H3CO H.....- 'cH3 
10 mmol) and D.MF (2 drops). The reaction was stirred until 
the evolution of gas ceased. The benzene was removed by rotary evaporation to give the 
corresponding acid chloride, which was used directly in the next step. 
The acid chloride was re-dissolved in CH2Ch (10 mL) at 0 °C. To this solution, a stirred 
mixture of methylamine (0.38 g, 12 mmol) and CH2Ch-aqueous 5% NaOH (1:1.5, 10 
mL) was added. After stirring at room temperature for 1 h, the reaction mixture was 
extracted by using chloroform (10 mL x 3). The organic layers were washed with water 
(15 mL x 2), dried over anhydrous MgS04, filtered, and the solvent was evaporated. The 
residue was purified by flash column chromatography (35% EtOAc/hexane) to afford the 
amide 97 (1.6 g, 77%) as a colorless oil; 1H NMR: o 6.86-6.77 (m, 3H, Ar-H), 5.55 (bs, 
1H, N-H), 3.88 (s, 6H, OCH3), 3.52 (s, 2H, H-a), 2.76 (d, N-CH3); 13C NMR: o 172.5, 
149.7, 148.8, 127.7, 122.1, 113.0, 112.0, 60.5, 56.3, 43.6, 26.9; MS (m/z): 209 (W+1, 
41), 151 (100), 91 (35). 
N-Benzyl-(3-methoxy-4-benzoxyl)phenylacetamide (97a) 
To a stirred solution of oxalyl chloride (1.1 mL, 5.8 mmol) in anhydrous benzene (50 
mL) were added compound 96a (2.1 g, 7.7 mmol) and DMF (2 drops). The reaction was 
stirred until the evolution of gas ceased. And then benzene was removed by rotary 
evaporation to give acid chloride, which was used directly in the next step. 
71 
The acid chloride was re-dissolved in CH2Ch (10 mL) at 0 °C. To above solution, a 
mL x 3). The organic layers were washed with water (15 mL x 2), dried over anhydrous 
MgS04 , filtered, and the solvent was evaporated. The residue was purified by flash 
column chromatography (35% EtOAc/hexane) to afford the amide 97a (2.1 g, 77%) as a 
colorless oil; 1H NMR: cS 7.52-7.11 (m, 10H, Ar-H), 6.78 (m, 3H, H-2, H-5, H-6), 5.81 
(bs, 1H, N-H), 5.13 (s, 2H, H-a"), 4.39 (s, 2H, H-a), 3.85 (s, 3H, -OCH3), 3.55 (s, 2H, 
H-a); MS (m/z): 365 (M+, 5), 91 (100). 
N-Methyl-3, 4-dimethoxyphenylacetamine (98) 
To a solution of amide 97 (1.3 g, 6.1 mmol) in anhydrous THF 
(20 mL) was added BF3/Et20 (0.32 mL, 2.5 mmol) under 
argon. The mixture was heated to gentle reflux and then added 
BHYTHF (1.0 M solution in THF, 15 mL, 15 mmol) dropwise. The reaction mixture was 
refluxed for 2 hand then cooled to 0 °C. Aqueous 20% HCl (15 mL) was added to the 
mixture and it was stirred at 0 °C for 1 h and then at room temperature for overnight. The 
reaction mixture was basified with aqueous 50% KOH solution and extracted with 
CHzCh (10 mL x 3). The combined organic layers were washed with water (20 mL x 3), 
dried over anhydrous MgS04 , filtered, and the solvent was evaporated to afford 98 (1.0 g, 
84%) as a colorless oil, which was pure enough to be used in the next step without 
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purification. 1H NMR: 8 6.84-6.74 (m, 3H, Ar-H), 4.81 (bs, 1H, N-H), 3.88 (s, 3H, 
OCH3), 3.87 (s, 3H, OCH3), 2.80 (m, 4H, H-a, H-j3), 2.45 (s, 3H, N-CH3). 
N-Benzyl-(3-methoxy-4-beozoxyl)phenylethylamine (98a) 
. To a solution of amide 97a (1.5 g, 4.2 mmol) in H,mD)w 
~·· I # H/): :~:.:::u~::g~:s;::::::::~~dto 
U U gentle reflux and then added dropwise BH3ffHF (1.0 M 
solution in THF, 14 mL, 14 mmol). The reaction mixture was refluxed for 2 hand then 
cooled to 0 °C. Aqueous 20% HCl (15 mL) was added to the mixture and it was stirred at 
0 °C for 1 h, and then at room temperature for overnight. The reaction mixture was 
basified with aqueous 50% KOH solution and extracted with CH2Ch (10 mL x 3). The 
combined organic layers were washed with water (20 mL x 3), dried over anhydrous 
MgS04 , filtered, and the solvent was evaporated to afford 98a (1.2 g, 84%) as a 
colorless oil, which was pure enough to be used in the next step without purification. 
N-Methyl-N -2-(3,4-dimethoxy )phenylethylformamide (99) 
H co To compound 98 (0.40 g, 2.1 mmol) in a 15 mL flask was 
3~ ~ /~' added a mixture ofHC02H and Ac20 (5.0 mL, 1:1) under 
H3CO ( CH3 
o argon. After stirring overnight at room temperature, the 
reaction was diluted with the addition of water (5.0 mL). Then the mixture was extracted 
with EtOAc (5.0 mL x 2). The organic layers were combined and washed with brine (10 
mL x 2), dried over MgS04, filtered, and the solvent was evaporated in vacuo. The 
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residue was purified by flash column chromatography (50% EtOAc/hexane) to afford 99 
(350 mg, 80%) as a colorless oil, which was used directly in the next step. 
N-Benzyl-N-[2-(3-methoxy-4-benzoxyl)phenylethylformamide (99a) 
J3" To a compound 98a (0.40 g, 1.2 mmol) in a 15 mL flask 
H3CO~a." 
0~ r(~o was added a mixture ofHC02H and Ac20 (5.0 mL, 1 :1) 
d a.' J under argon. After stirring overnight at room ~I =:::::::..... temperature, the reaction was diluted with the addition 
of water (5 mL). The mixture was extracted with EtOAc (5 mL x 2). The combined 
organic layers were washed with brine (1 0 mL ), dried over MgS04, filtered, and the 
solvent was evaporated in vacuo. The residue was purified by flash column 
chromatography (50% EtOAc/hexane) to afford 99a (347 mg, 80%) as a colorless oil, 
which was used directly in the next step. MS (m/z): 375 (M+ +2, 2), 240 (25), 91 (1 00) . 
6, 7 -Dimethoxy-N-methyltetrahydroisoquinoline (1 00) 
Compound 99 (300 mg, 1.4 mmol), POCb (1.0 mL) and 
5 4 
H3COL03 6 I 2 benzene ( 10 mL) were combined under an atmosphere of argon ~ N....._ 
H3CO 7 CH3 
8 1 and bought to a gentle reflux. After approximately 8 h, the 
solvent was evaporated on a rotary evaporator and the residual POCb was evaporated on 
a vacuum pump for 1 h. 
The residue was re-dissolved in MeOH (1 0 mL), and the solution was cooled to 
-78 °C in a dry ice/acetone bath. To this solution was added NaBH4 (40 mg, 1.0 mmol) in 
five portions over a period of 5 h. The reaction was then quenched by the addition of 
aqueous 10% HCl (10 mL) and stirred at room temperature for 10 min. The MeOH was 
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evaporated on a rotary evaporator, and the residue was re-dissolved in CHzCh (15 mL) 
and transferred to a separatory funnel containing HzO (5.0 mL). The combined aqueous 
layers were extracted with CH2Ch (3 x 10 mL). The combined extracts were washed with 
brine (3 x 5.0 mL), dried over MgS04, filtered, and the solvent was evaporated. The 
residue was purified by flash column chromatography (5% MeOH/CHzCh) to give 100 
(240 mg, 88%) as a colorless oil; 1H NMR: cS 6.59 (s, 1H, H-8), 6.51 (s, 1H, H-5), 3.84 (s, 
3H, OCH3), 3.83 (s, 3H, OCH3), 3.50 (s, 2H, H-1), 2.85 (t, 1=6.0 Hz, 2H, H-3), 2.66 (t, 
1=6.0 Hz, 2H, H-4), 2.44 (s, 3H, N-CH3); MS (m/z): 206 {W, 68), 164 (100), 121 (22), 
58 (62). 
N-Benzyl-(6-methoxy-7-benzoxyl)-1,2,3,4-tetrahydroisoquinoline (100a) 
5 4 
Compound 99a (1.2 g, 3.2 mmol), POCh (1.0 mL) and 
H3C0~3 
~~ benzene (20 mL) were combined under an atmosphere 
d o 
7 
: I No
2 
" of argon and bought to a gentle reflux. After 
a ' ~ ~ I approximately 8 h, the solvent was evaporated on a 
rotary evaporator and the residual POCh was evaporated on a vacuum pump for an 1 h. 
The residue was re-dissolved in MeOH (10 mL), and the solution was cooled to 
-78 °C in a dry ice/acetone bath. To this solution was added NaB~ (58 mg, 1.5 mmol) in 
five portions over a period of 5 h. The reaction was then quenched by the addition of 
aqueous 10% HCl (10 mL) and stirred at room temperature for 10 min. The MeOH was 
evaporated on a rotary evaporator and the residue was re-dissolved in CH2Ch (15 mL) 
and transferred to a separatory funnel containing H20 (5 mL). The combined aqueous 
layers were extracted with CH2Ch (3 x 10 mL). The combined extracts were washed with 
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brine (3 x 5 mL), dried over MgS04, filtered, and the solvent was evaporated in vacuo. 
The residue was purified by flash column chromatography (5% MeOH/CH2Ch) to give 
lOOa (1.3 g, 88%) as a colorless oil; 1H NMR: B 7.42-7.20 (m, 10H, Ar-H), 6.62 (s, 1H, 
H-5), 6.51 (s, 1H, H-8), 5.07 (s, 2H, H-a'), 3.84 (s, 3H, OCH3), 3.65 (s, 2H, H-1), 3.49 (s, 
2H, H-a), 2.81 (t, 1=5.5 Hz, 2H, H-4), 2.70 (t, 1=5.5 Hz, 2H, H-3). 
N-Ethylcarbonyl-7-ethoxycarbonyloxy-6-methoxy-1,2,3,4-tetrahydroisoquinoline 
(105) 
To a solution of 103 (0.56 g, 3.1 mmol) in CH2Ch (10 
mL), aqueous saturated solution of NaHC03 (10 mL) 
was added. The resulting two-phase mixture was 
stirred vigorously at 0 °C for 0.5 h, and then ethyl 
chloroformate (1.2 mL, 9.3 mmol) was added to the mixture dropwise. The reaction 
mixture was warmed to room temperature and stirred over 3 h. The organic layer was 
separated. The aqueous phase was extracted using CH2Ch (10 mL x 2). The combined 
organic layers were washed with water (5 mL x 2), brine (5 mL), dried over MgS04 , 
filtered, and concentrated in vacuo. The residue was purified by flash column 
chromatography (50% EtOAc/hexane) to give 105 (0.86 g, 85%) as a colorless oil; 1H 
NMR: B 6.78 (s, 1H, H-5), 6.64 (s, 1H, H-8), 4.44 (s, 2H, H-1), 4.20 (q, 1=1.0 Hz, 2H, H-
a), 4.08 (q, 1=1.0 Hz, 4H, H-a'), 3.72 (s, 3H, OCH3), 3.58 (bs, 2H, H-4), 2.71 (s, 2H, H-
3), 1.30 (t, 1=7.0 Hz, 3H, a-CH3), 1.19 (t, 1=7.0 Hz, 3H, a'-CH3); 13C NMR: B 155.9, 
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153.8, 149.9, 138.9, 133.6, 126.0 (b), 120.4, 113.1, 65.2, 61.8, 56.3, 45.3, 41.5 (b), 28.7 
(b), 15.1, 14.5; MS (m/z): 323 {W, 8), 294 (96), 222 (100). 
N-Ethylcarbonyl-7 -ethoxycarbonyloxy-6-methoxy-1,2,3,4-tetrahydroisoquinolone 
(106) 
To a mixture of 105 (120 mg, 0.37 mmol) and Nal04 
(340 mg, 1.5 mmol) in CCl4-CH3CN-H20 (1:1:1.5, 5.0 
mL), Ru02 (1.2 mg, 2.2 mol%) was added at once. 
The reaction mixture was stirred for 3 h at room 
temperature, and then CH2Ch (5.0 mL) and H20 (5.0 mL) were added to the mixture. 
The organic layer was separated, and the aqueous layer was extracted with CH2Ch (10 
mL x 2). The combined organic layers were washed with water (5.0 mL x 2), dried over 
MgS04, filtered, and the solvent was evaporated. The residue was purified by preparative 
TLC (50%, EtOAc/hexane) to give 106 (85 mg, 68%) as a colorless oil; 1H NMR: 5 7.94 
(s, 1H, H-5), 6.77 (s, 1H, H-8), 4.38 (q, 1=6.9 Hz, 2H, H-a), 4.33 (q, 1=6.9 Hz, 2H, H-
a), 4.09 (t, 1=5.1 Hz, 2H, H-4), 3.01 (t, 1=5.1 Hz, 2H, H-3), 1.36 (m, 6H, a-CH3, a'-
CH3); 13C NMR: 5 162.8, 155.2, 154.7, 153.1, 139.8, 139.4, 123.9, 121.9, 110.9, 65.3, 
63.4, 56.3, 44.6, 28.5, 14.4, 14.2; MS (m/z): 338 (M+, 3), 265 (21), 164 (25), 136 (19), 29 
(100). 
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Chapter 4 
Future Work 
4.1 Further Studies of the Selective Formation of the Ring-Closure Products via 
BNC Reaction 
Br Br 
Br 
TBSO 
OH 
107 108 109 
I 
'!HI 
' 
(-)-cycleanine (8) 
110 
Scheme 26. 
From the previous studies reported herein, the BNC reaction of compounds 57 or 
81 always resulted in the formation of a pair of regioisomers because of the presence of 
two available ring-closure sites. As a result, lower yields of the target ring-closure 
products would result, and this also makes separation of the resulting pair of regioisomers 
difficult. A possible solution to this problem would involve blocking the undesired 
closure site of the precursor, e.g. 107 and 108, which could result in a unique target ring-
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closure product, e.g. 109 (Scheme 26). The blocking group should survive the BNC 
reaction conditions and the subsequent procedures. Furthermore, the blocking group 
should also be removed easily at a later stage, in a selective manner. 
With the above considerations, a bromine atom was considered to be a suitable 
blocking group. This proposal is briefly outlined in Scheme 26. The advantage of this 
proposal is that the chiral auxiliary, the benzyl group and the blocking group of 109 all 
could be removed simultaneously in a later Pd/C-catalyzed hydrogenolysis step to afford 
the key intermediate 110. However, additional research was not undertaken into 
exploring the stability of the bromine atom in the BNC and subsequent steps. 
4.2 Further Proposal for the Diaryl Ether Formation Step 
Thus far, attempts at the synthesis of the diaryl-ether linkages required to 
construct the macrocycle of cycleanine (8) resulted in failure. However, it should be 
pointed out that a much effort is currently devoted by many research groups to develop 
better methods for the synthesis of diary! ethers in searching for new synthetic routes to a 
wide range of biologically active compounds. However, due to time constraints, only the 
Cu(0Ac)2-mediated diary! ether formation methodology was explored for this thesis. 
4.2.1 Further Examination of Ullmann Ether Synthesis 
As an example of a modification to the classical Ullmann methods, the procedure 
developed by Smith69 involving the use of catalytic copper(!) iodide and ultrasound gives 
better yields of diary! ethers at lower temperature (Scheme 27). Future attempts into 
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exploring the formation of the macrocyclization strategies for the synthesis of diaryl ether 
with the use of this Ullmann methodology could be focused on varying reaction 
conditions, such as reaction temperature, reaction time or varying the amounts and/or 
nature of the catalyst. 
V OHBruMe + I ~ K2C03, Cui (0.05 eq.) # 140 °C, ultrasound, 97% r(YO'l(YMe vV 
111 112 113 
Scheme 27. 
4.2.2 Further Examination of SNAr-based Diary I Ether Formation Reaction 
An example from the Sawye?0 group illustrates that even the sterically crowded 
nucleophile 2-tert-butylphenol, which is usually unreactive under normal Ulllmann 
conditions, added smoothly to 4-bromobenzonitrile to give diaryl ether 116 (Scheme 28). 
&t-Bu OH + # 
114 
I ~ KFI Alz03, 18-crown-6 Br'Q 
# MeCN, reflux, 83% 
CN 
115 
Scheme 28. 
116 
Another example from Zhu 71 shows an efficient intramolecular SNAr macrocyclization 
approach (Scheme 29). Similarly, Wang34 used a base-mediated SNAr coupling for 
construction of the diaryl ether key synthetic intermediate 121 in his synthesis of(-)-
tejedine (Scheme 30). The ortho-nitroarylfluoride 120 reacted with phenol 119 to afford a 
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diaryl ether compound 121 in a very high yield (90%) using CsF in DMSO at room 
temperature. 
MeO 
F 
NOz 
117 
119 
° CsF, DMF (0.01 M) 
90% 
Scheme29. 
121 
Scheme 30. 
81 
0 
118 
120 
Future attemps to form the diaryl-ether linkages in the synthesis of cycleanine 
should evaluate the application of a similar base-mediated SNAr coupling methodology to 
F 
--~ -~ 
N~ 
58 122 
a) 1. Fe, HCI; 
2. NaN02, HCI; 
3. EtOH; (-)-Cycleanine (8) ~ - - - - - - - - - - - - - - -
b) H2, Pd/C; 
c) HCHO, MeCN, NaBH3CN. 
Scheme 31. 
I 
I 
: CsF, DMSO, rt, 24 h 
I t N~ 
N~ 124 
that which has been demonstrated to be effective in the synthesis of (-)-tejedine. Success 
utilizing this methodology would result in the completion of the target molecule, which is 
outlined in Scheme 31. Upon application of the Schotten-Baumann reaction conditions, 
chiral amine 58 and carboxylic acid 121 could afford a key intermediate 123, a precursor 
for the desired diaryl ether coupling reaction. Under SNAr coupling reaction conditions, a 
homocoupling reaction of 123 could complete the key intermediate 124. Selective 
removal of the nitro group and the chiral auxiliary of 124 and followed by methylation 
could afford the target compound (-)-cycleanine (8). It should be pointed out that 122 
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could be synthesized from 4-fluoro-3-nitrophenylacetonitrile, a commercially available 
compound. 
However, because an ortho-substituted electron-withdrawing group is necessary 
to activate the aryl fluoride, experimentation to evaluate selective removal of the 
electron-withdrawing group (e.g. -N02) will require attention. Therefore, model studies 
on the coupling reaction of aryl fluorides bearing ortho-substituted electron-withdrawing 
groups need to be evaluated. 
4.3 Future Proposals for Improvement in Construction of the Tetrahydro-
isoquinolones 
It should be considered that any current or future progress towards the syntheses 
of tetrahydroisoquinolones can also be of help in designing syntheses of BBIQs. The 
selective oxidation of tetrahydroisoquinolines was based on the selection of appropriate 
oxidation reagent and modification of the precursor to the oxidation step. It is reasonable 
to consider that future endeavors towards the syntheses of tetrahydroisoquinolones or 
BBIQs containing tetrahydroisoquinolone unit will be focused around these two 
particular aspects. 
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